Delaware |
3714 |
37-1827430 | ||
(State or other jurisdiction of incorporation or organization) |
(Primary Standard Industrial Classification Code Number) |
(I.R.S. Employer Identification No.) |
Large accelerated filer |
☐ |
Accelerated filer |
☐ | |||
☒ |
Smaller reporting company |
|||||
Emerging growth company |
1 | ||||
2 | ||||
4 | ||||
8 | ||||
9 | ||||
44 | ||||
45 | ||||
46 | ||||
60 | ||||
76 | ||||
86 | ||||
91 | ||||
102 | ||||
108 | ||||
110 | ||||
118 | ||||
122 | ||||
125 | ||||
126 | ||||
127 | ||||
F-1 |
• | our ability to realize the benefits of the Merger, which may be affected by, among other things, competition and our ability to grow and manage growth profitably; |
• | changes in our strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; |
• | our product development timeline and expected start of production; |
• | the implementation, market acceptance and success of our business model; |
• | our ability to scale in a cost-effective manner; |
• | developments and projections relating to our competitors and industry; |
• | the impact of health epidemics, including the COVID-19 pandemic, on our business and the actions we may take in response thereto; |
• | our expectations regarding our ability to obtain and maintain intellectual property protection and not infringe on the rights of others; |
• | expectations regarding the time during which we will be an emerging growth company under the JOBS Act; |
• | our future capital requirements and sources and uses of cash; |
• | our ability to obtain funding for our operations; |
• | our business, expansion plans and opportunities; and |
• | the outcome of any known and unknown litigation and regulatory proceedings. |
• | Merger Sub merged with and into Old AEye, with Old AEye surviving as a wholly-owned subsidiary of the Company; |
• | each share of common stock of Merger Sub issued and outstanding immediately prior to the Effective Time was automatically converted into an equal number of shares of common stock of validly issued, fully paid and nonassessable shares of common stock of Old AEye, which shares constitute the only outstanding shares of capital stock of Old AEye held by us; |
• | all issued and outstanding shares of Old AEye’s capital stock (other than shares held by us, CF Finance Holdings III, LLC (the “Sponsor”) or held in treasury) converted into an aggregate of 122,509,667 shares of Common Stock. |
• | all shares of Old AEye’s capital stock held in treasury were canceled without any conversion thereof; |
• | all of the outstanding options of Old AEye to acquire Old AEye’s common stock were assumed by the Company and converted into options to acquire an aggregate of 29,415,292 shares of Common Stock; |
• | all of the outstanding restricted stock units (“RSUs”) of Old AEye to acquire Old AEye’s common stock were assumed by the Company and converted into RSUs to acquire an aggregate of 1,724,283 shares of Common Stock; |
• | all of the 5,750,000 outstanding shares of CF III’s Class B common stock, par value $0.0001 per share, held by the Sponsor and the former independent directors of CF III converted into an aggregate of 5,750,000 shares of Common Stock; |
• | all of the 500,000 private placement units held by the Sponsor were separated, pursuant to their terms, into 500,000 shares of Common Stock and 166,666 Warrants; and |
• | all of the remaining outstanding Company units were separated, pursuant to their terms, into one share of Common Stock and one-third (1/3) of one Warrant (and CF III’s units ceased trading on Nasdaq). |
• | We are an early stage company with a history of losses, and we expect to incur significant expense and continuing losses for the foreseeable future; |
• | Our limited operating history makes it difficult to evaluate our future prospects and the risks and challenges we may encounter; |
• | We operate in a highly competitive industry involving emerging technology. Certain of our competitors in the lidar technology space have in the past offered, and may in the future offer, their products and services on terms that we and/or our partners are unwilling to match, which may adversely affect our market share; |
• | Our business could be materially and adversely affected by the current global COVID-19 pandemic or other epidemics and outbreaks; |
• | We continue to implement strategic initiatives designed to grow our business. These initiatives may prove more costly than we currently anticipate and we may not succeed in increasing our revenue in an amount sufficient to offset the costs of these initiatives and to achieve and maintain profitability; |
• | If our deterministic artificial intelligence-driven sensing system is not selected for inclusion in ADAS, by OEMs or their suppliers, our business will be materially and adversely affected; |
• | Our products require key components and critical raw materials and our inability to reduce and control the cost of such components and raw materials could negatively impact the adoption of our products and accordingly, our financial condition and operating results. |
• | Continued pricing pressures, OEM and Tier 1 supplier cost reduction initiatives and the ability of OEMs and Tier 1 suppliers to re-source or cancel vehicle or technology programs may result in lower than anticipated revenue, or cause substantial losses to be incurred, which may adversely affect our business; |
• | We expect to incur substantial research and development (“R&D”) costs and devote significant resources to identifying and commercializing new products, which could significantly reduce our profitability and may never result in revenue to us; |
• | If market adoption of lidar does not continue to develop, or develops more slowly than we expect, our business will be adversely affected; |
• | We are highly dependent on the services of our executive officers, in particular, Luis Dussan, one of our founders, and Blair LaCorte, our Chief Executive Officer; |
• | We may experience difficulties in managing our growth and expanding our operations; |
• | We rely on third-party suppliers and because some of the raw materials and key components in our products come from limited or single source suppliers, we are susceptible to supply shortages, longer than anticipated lead times for components, and supply changes, any of which could disrupt our supply chain and could delay deliveries of our products to customers; |
• | Because our sales have been primarily to customers making purchases for R&D projects and our current orders are project-based, we expect our results of operations to fluctuate on a quarterly and annual basis, which could cause our stock price to fluctuate or decline; |
• | We may face risks associated with our reliance on certain artificial intelligence and machine learning models; |
• | Our outsourced manufacturing business model for the Industrial and Mobility markets may not be successful, which could harm our ability to deliver products and recognize revenue in the Industrial and Mobility markets; |
• | The complexity of our products could result in unforeseen delays or expenses from undetected defects, errors or reliability issues in our hardware or software which could reduce the market adoption of our new products, damage our reputation with current or prospective customers, expose us to product liability and other claims and thereby adversely affect our operating costs; |
• | We may be subject to product liability or warranty claims that could result in significant direct or indirect costs, which could adversely affect our business and operating results; and |
• | Our expectations regarding our ability to obtain and maintain intellectual property protection and not infringe on the rights of others. |
Shares of Common Stock offered by the Selling Securityholders | 68,139,193 shares. | |
Shares of Common Stock prior to exercise of all Warrants | 154,404,302 shares (as of August 16, 2021). | |
Shares of Common Stock outstanding assuming the exercise of all Warrants and options referenced above | 166,143,982 shares (as of August 16, 2021). | |
Warrants offered by the Selling Securityholders | 166,666 Warrants. | |
Warrants outstanding | 7,833,332 Warrants (as of August 16, 2021). | |
Exercise price per share pursuant to the Warrants | $11.50 per share, subject to adjustment as described herein. | |
Use of proceeds | We will not receive any proceeds from the sale of shares by the Selling Securityholders. We will receive the proceeds from any exercise of the Warrants for cash, which we intend to use for general corporate and working capital purposes. See “ Use of Proceeds | |
Risk factors | You should carefully read the “Risk Factors” beginning on page 9 and the other information included in this prospectus for a discussion of factors you should consider carefully before deciding to invest in our Common Stock or Warrants. | |
Nasdaq symbol for our Common Stock | “LIDR” | |
Nasdaq symbol for our Warrants | “LIDRW” |
• | continue to utilize our third-party partners for design, testing and commercialization; |
• | expand our operations and supply chain capabilities to produce our lidar solutions, including costs associated with outsourcing the production of our lidar solutions; |
• | expand our design, development and servicing capabilities; |
• | build up inventories of parts and components for our lidar solutions; |
• | produce an inventory of our lidar solutions; |
• | increase our sales and marketing activities and develop our distribution infrastructure; and |
• | increase our general and administrative spending to meet the requirements of operating as a public company. |
• | develop and commercialize our products; |
• | produce and deliver lidar and software products meeting acceptable performance metrics; |
• | forecast our revenue and budget for and manage our expenses; |
• | attract new customers and retain existing customers; |
• | develop, obtain or progress strategic partnerships; |
• | comply with existing and new or modified laws and regulations applicable to our business; |
• | plan for and manage capital expenditures for our current and future products, and manage our supply chain and supplier relationships related to our current and future products; |
• | anticipate and respond to macroeconomic changes as well as changes in the markets in which we operate; |
• | maintain and enhance the value of our reputation and brand; |
• | effectively manage our growth and business operations, including the impacts of the COVID-19 pandemic on our business; |
• | develop and protect our intellectual property; |
• | hire, integrate and retain talented people at all levels of our organization; and |
• | successfully develop new solutions to enhance the experience of our customers. |
• | investing in R&D; |
• | expanding our sales and marketing efforts to attract new customers and strategic partners; |
• | investing in new applications and markets for our products; |
• | further enhancing our manufacturing processes and partnerships; |
• | protection of our intellectual property; and |
• | investing in legal, accounting, and other administrative functions necessary to support our operations as a public company. |
• | the timing and magnitude of orders and shipments of our products in any quarter; |
• | decreases in pricing that we may adopt to drive market adoption or in response to competitive pressure; |
• | our ability to retain our existing customers and strategic partners and attract new customers and strategic partners; |
• | our ability to develop, introduce, manufacture and ship, in a timely manner, products that meet customer requirements; |
• | disruptions in our sales channels or termination of our relationships with important channel partners; |
• | delays in customers’ purchasing cycles or deferments of customers’ purchases in anticipation of new products or updates from us or our competitors; |
• | fluctuations in demand for our products; |
• | the mix of products sold or licensed in any quarter; |
• | the duration or worsening of the global COVID-19 pandemic and the time it takes for economic recovery; |
• | the timing and rate of broader market adoption of ADAS or autonomous systems utilizing our solutions across the automotive and other market sectors; |
• | the timing and scale of the market acceptance of lidar generally; |
• | further technological advancements by our competitors and other market participants; |
• | the ability of our customers and strategic partners to commercialize systems that incorporate our products; |
• | any change in the competitive dynamics of our markets, including consolidation of competitors, regulatory developments and new market entrants; |
• | our ability to effectively manage or outsource management of our inventory; |
• | changes in the source, cost, availability of and regulations pertaining to components and materials we use in our products; |
• | adverse litigation, judgments, settlements or other litigation-related costs, or claims that may give rise to such costs; and |
• | general economic, industry and market conditions, including trade disputes. |
• | foreign currency fluctuations; |
• | local economic conditions; |
• | political instability; |
• | import and export requirements; |
• | foreign government regulatory requirements; |
• | reduced protection for intellectual property rights in some countries; |
• | tariffs and other trade barriers and restrictions; and |
• | potentially adverse tax consequences. |
• | exchange rate fluctuations; |
• | political and economic instability, international terrorism and anti-American sentiment, particularly in emerging markets; |
• | global or regional health crises, such as the COVID-19 pandemic or other epidemics or outbreaks of other contagions; |
• | potential for violations of anti-corruption laws and regulations, such as those related to bribery and fraud; |
• | preference for locally branded products, and laws and business practices favoring local competition; |
• | potential consequences of, and uncertainty related to, the “Brexit” process in the United Kingdom, which could lead to additional expense and complexity in doing business there; |
• | increased difficulty in managing inventory; |
• | delayed revenue recognition; |
• | less effective protection of intellectual property; |
• | stringent regulation of the autonomous or other systems or products using our products and stringent consumer protection and product compliance regulations, including but not limited to the General Data Protection Regulation in the European Union, European competition law, the Restriction of Hazardous Substances Directive, the Waste Electrical and Electronic Equipment Directive and the European Ecodesign Directive that are costly to comply with and may vary from country to country; |
• | difficulties and costs of staffing and managing foreign operations; |
• | import and export laws and the impact of tariffs; |
• | changes in local tax and customs duty laws or changes in the enforcement, application or interpretation of such laws; and |
• | U.S. government’s restrictions on technology transfers to certain countries. |
• | changes in tax laws (including tax rates) or the regulatory environment; |
• | changes in accounting and tax standards or practices; |
• | changes in the composition of operating income by tax jurisdiction; and |
• | our operating results before taxes. |
• | actual or anticipated fluctuations in our operating results or future prospects; |
• | our announcements or our competitors’ announcements of new products and services; |
• | the public’s reaction to our press releases, our other public announcements and our filings with the SEC; |
• | strategic actions by us or our competitors, such as acquisitions or restructurings; |
• | new laws or regulations or new interpretations of existing laws or regulations applicable to our business; |
• | changes in accounting standards, policies, guidance, interpretations or principles; |
• | changes in our growth rates or our competitors’ growth rates; |
• | developments regarding our patents or proprietary rights or those of our competitors; |
• | ongoing legal proceedings; |
• | commencement of, or involvement in, litigation involving the combined company; |
• | our ability to raise additional capital as needed; |
• | changes in our capital structure, such as future issuances of securities or the incurrence of new or additional debt; |
• | the volume of shares of Common Stock available for public sale and the size of our public float; |
• | additions and departures of key personnel; |
• | concerns or allegations as to the safety or efficacy of our products and services; |
• | sales of stock by us or members of our management team, our board of directors (the “Board”) or certain significant stockholders; |
• | changes in stock market analyst recommendations or earnings estimates regarding our stock, other comparable companies or our industry generally; and |
• | changes in financial markets or general economic conditions, including the effects of recession or slow economic growth in the U.S. and abroad, interest rates, fuel prices, international currency fluctuations, corruption, political instability, acts of war or terrorism, and the COVID-19 pandemic or other public health crises. |
• | not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act; |
• | not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (i.e., an auditor discussion and analysis); |
• | reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements and registration |
• | exemptions from the requirements of holding a nonbinding advisory vote of stockholders on executive compensation, stockholder approval of any golden parachute payments not previously approved and having to disclose the ratio of the compensation of our chief executive officer to the median compensation of our employees. |
• | the (a) historical audited financial statements of CF III as of and for the year ended December 31, 2020 and (b) historical unaudited condensed financial statements of CF III as of and for the six months ended June 30, 2021; and |
• | the (a) historical audited consolidated financial statements of AEye as of and for the year ended December 31, 2020 and (b) historical unaudited condensed consolidated financial statements of AEye as of and for the six months ended June 30, 2021 |
• | the cancellation of each issued and outstanding share of AEye Preferred Stock and the conversion into the right to receive a number of shares of Class A Common Stock equal to the Exchange Ratio; |
• | the cancellation of each issued and outstanding share of AEye capital stock (including shares of AEye Common Stock resulting from the conversion of the AEye convertible equity instruments) and the conversion into the right to receive a number of shares of Class A Common Stock equal to the Exchange Ratio; |
• | the conversion of all outstanding AEye convertible equity instruments into a number of shares of AEye Common Stock equal to (i) the sum of the aggregate principal amount of the AEye convertible equity instruments then outstanding plus all dividends accrued thereon, divided by (ii) the quotient obtained by dividing $250,000,000 by the Fully-Diluted AEye Shares, immediately prior to the Effective Time. At the Effective Time, the AEye Common Stock will then convert to Class A Common Stock based on the Exchange Ratio; |
• | the assumption and conversion of each then outstanding AEye Option, whether vested or unvested, into an option to purchase shares of Class A Common Stock on the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former AEye Option, with the number of shares exercisable and the exercise price adjusted using the Exchange Ratio; |
• | the assumption and conversion of each then outstanding AEye Warrant into a warrant to purchase shares of Class A Common Stock on the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former AEye Warrant, with the number of shares exercisable and the exercise price adjusted using the Exchange Ratio; and |
• | the assumption and conversion of each then outstanding AEye RSU into an RSU with the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former AEye RSU, with the number of shares to be received on settlement adjusted using the Exchange Ratio. |
• | Historical AEye stockholders comprising a relative majority of the voting power of the Combined Entity and having the ability to nominate the members of the Combined Entity Board; |
• | Historical AEye Stockholders and holders of AEye convertible equity instruments holding 74.7% (assuming no redemptions) of the Combined Entity; |
• | AEye’s relative historical size (based on revenues, total assets (excluding cash held in the Trust Account), and number of employees) being significantly larger than CF III; |
• | AEye’s historical operations prior to the acquisition comprising the only ongoing operations of the Combined Entity; and |
• | AEye’s historical senior management comprising a majority of the senior management of the Combined Entity. |
• | CF III issued and sold 22,000,000 shares of its Class A Common Stock at a purchase price of $10.00 per share pursuant to the PIPE Investment; and |
• | Prior to Closing, AEye was to either repay the Paycheck Protection Program (“PPP”) loan (“PPP Loan”), including associated interest, or if the PPP Loan had not been previously repaid or forgiven, place an amount necessary to satisfy the repayment of the PPP Loan in an escrow account. On June 19, 2021, the Company received notice of the PPP forgiveness payment made to Silicon Valley Bank (SVB) by the Small Business Administration in the amount of $2,270 thousand in principal and $27 thousand in interest. This amount represents the forgiveness of the total PPP Loan from SVB and, as such, AEye is not required to repay the PPP Loan or place the amount required to repay the PPP Loan into an escrow account. |
• | No Redemptions Scenario — This scenario assumes that no shares of CF III Class A Common Stock are redeemed; and |
• | Maximum Redemptions Scenario — This scenario assumes that 20,958,853 shares of CF III Class A Common Stock are redeemed for an aggregate payment of $211,684 thousand, which is derived from the number of shares that could be redeemed in connection with the Business Combination at an assumed redemption price of approximately $10.10 per share based on the Trust Account balance as of June 30, 2021. |
Pro Forma Combined (Assuming No Redemptions Scenario) |
Pro Forma Combined (Assuming Maximum Redemptions Scenario) |
|||||||||||||||
Stockholder |
Shares |
% |
Shares |
% |
||||||||||||
Former CF III Class A public stockholders |
23,000,000 | 11.3 | % | 2,041,147 | 1.1 | % | ||||||||||
Sponsor, other CF III initial stockholders and transferees (1) |
6,250,000 | 3.0 | % | 6,250,000 | 3.4 | % | ||||||||||
Former AEye Stockholders (including holders of AEye Preferred Stock) and holders of AEye Convertible Equity Instruments (2)(3) |
152,223,647 | 74.7 | % | 152,223,647 | 83.2 | % | ||||||||||
PIPE Investors (3) |
22,500,000 | 11.0 | % | 22,500,000 | 12.3 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Pro forma common stock outstanding at June 30, 2021 |
203,973,647 | 100 | % | 183,014,794 | 100 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assumed options and assumed Warrants (3) |
(30,002,411 | ) | (30,002,411 | ) | ||||||||||||
|
|
|
|
|||||||||||||
Pro forma common stock outstanding at June 30, 2021 |
173,971,236 | 153,012,383 | ||||||||||||||
|
|
|
|
(1) | Amount reflects 5,750,000 shares of CF III Class B Common Stock held by the Sponsor and the other CF III initial stockholders and converted into Class A Common Stock at Closing and 500,000 shares of CF III Class A Common Stock purchased by the Sponsor in the Private Placement. |
(2) | Amount is based on 40,895,270 AEye Shares outstanding as of June 30, 2021, by applying the Treasury Stock Method and converted at an Exchange Ratio (as of June 30, 2021) of 3.7223 pursuant to the Merger Agreement. |
(3) | Number of outstanding shares assumes the issuance of approximately 30,002,411 shares of Class A Common Stock underlying Assumed Options and Assumed Warrants, by applying the Treasury Stock Method, that do not represent legally outstanding shares of Class A Common Stock at closing. |
(4) | Reflects 1,450,000 shares of the Class A Common Stock subscribed for by current holders of AEye capital stock and AEye convertible equity instruments in the PIPE Investment, 20,550,000 shares of Class A Common Stock subscribed for by third party investors in the PIPE Investment and 500,000 shares of Class A Common Stock subscribed for by the Sponsor in the PIPE Investment. |
As of June 30, 2021 |
Assuming No Redemptions |
Assuming Maximum Redemptions |
||||||||||||||||||||||||||||||
(In thousands, except share and per share data) | AEye (Historical) |
CF III (Historical) |
Transaction Accounting Adjustments |
Pro Forma Combined |
Transaction Accounting Adjustments |
Pro Forma Combined |
||||||||||||||||||||||||||
ASSETS |
||||||||||||||||||||||||||||||||
CURRENT ASSETS: |
||||||||||||||||||||||||||||||||
Cash and cash equivalents |
$ | 11,226 | $ | 128 | $ | 232,305 | A | $ | 413,661 | $ | (211,684 | ) | J | $ | 201,977 | |||||||||||||||||
(22,249 | ) | C | ||||||||||||||||||||||||||||||
(27,788 | ) | D | ||||||||||||||||||||||||||||||
225,000 | E | |||||||||||||||||||||||||||||||
(3,461 | ) | B | ||||||||||||||||||||||||||||||
(1,500 | ) | R | ||||||||||||||||||||||||||||||
Accounts receivable, net |
138 | 138 | 138 | |||||||||||||||||||||||||||||
Inventories, net |
4,468 | — | 4,468 | 4,468 | ||||||||||||||||||||||||||||
Prepaid and other current assets |
1,711 | 467 | — | 2,178 | 2,178 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total current assets |
17,543 | 595 | 402,307 | 420,445 | (211,684 | ) | 208,761 | |||||||||||||||||||||||||
Cash held in trust account |
232,305 | (232,305 | ) | A | — | — | ||||||||||||||||||||||||||
Property and equipment, net |
4,697 | 4,697 | 4,697 | |||||||||||||||||||||||||||||
Other noncurrent assets |
6,040 | 147 | (3,859 | ) | C | 2,328 | 2,328 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total assets |
$ |
28,280 |
$ |
233,047 |
$ |
166,143 |
$ |
427,470 |
$ |
(211,684 |
) |
$ |
215,786 |
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||||||||||||||||||||||||||
CURRENT LIABILITIES: |
||||||||||||||||||||||||||||||||
Accounts payable |
4,782 | 109 | 4,891 | 4,891 | ||||||||||||||||||||||||||||
Accrued expenses and other current liabilities |
6,048 | 81 | (425 | ) | C | 5,704 | 5,704 | |||||||||||||||||||||||||
Deferred revenue |
272 | 272 | 272 | |||||||||||||||||||||||||||||
Convertible notes |
37,759 | (37,758 | ) | L | 1 | 1 | ||||||||||||||||||||||||||
Borrowings - net of issuance costs, current portion |
11,334 | 3,461 | (2,270 | ) | K | 9,064 | 9,064 | |||||||||||||||||||||||||
(3,461 | ) | B | ||||||||||||||||||||||||||||||
Franchise tax payable |
100 | 100 | 100 | |||||||||||||||||||||||||||||
Income tax payable |
— | — | — | |||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total current liabilities |
60,195 | 3,751 | (43,914 | ) | 20,032 | — | 20,032 | |||||||||||||||||||||||||
Deferred rent, noncurrent |
3,333 | — | 3,333 | 3,333 | ||||||||||||||||||||||||||||
Borrowings - net of issuance, noncurrent |
1,242 | — | (229 | ) | O | 1,013 | 1,013 | |||||||||||||||||||||||||
Warrant liability |
12,612 | (12,343 | ) | P | 269 | 269 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total liabilities |
$ | 64,770 | $ | 16,363 | $ | (56,486 | ) | $ | 24,647 | $ | — | $ | 24,647 | |||||||||||||||||||
COMMITMENTS AND CONTINGENCIES |
||||||||||||||||||||||||||||||||
Common Stock subject to redemption |
211,684 | (211,684 | ) | F | — | — |
As of June 30, 2021 |
Assuming No Redemptions |
Assuming Maximum Redemptions |
||||||||||||||||||||||||||||||
(In thousands, except share and per share data) | AEye (Historical) |
CF III (Historical) |
Transaction Accounting Adjustments |
Pro Forma Combined |
Transaction Accounting Adjustments |
Pro Forma Combined |
||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (DEFICIT): |
||||||||||||||||||||||||||||||||
Preferred stock |
$ | 62,639 | $ | — | $ | (62,639 | ) | G | $ | — | $ | $ | — | |||||||||||||||||||
Common stock |
— | — | — | |||||||||||||||||||||||||||||
Class A common stock |
— | — | 3 | E | (6 | ) | (2 | ) | J | (8 | ) | |||||||||||||||||||||
2 | F | |||||||||||||||||||||||||||||||
(12 | ) | H | ||||||||||||||||||||||||||||||
— | L | |||||||||||||||||||||||||||||||
1 | M | |||||||||||||||||||||||||||||||
— | N | |||||||||||||||||||||||||||||||
Class B common stock |
1 | (1 | ) | M | — | — | ||||||||||||||||||||||||||
Additional paid-in capital |
10,239 | 9,458 | (26,109 | ) | C | 539,469 | (211,682 | ) | J | 327,787 | ||||||||||||||||||||||
224,998 | E | |||||||||||||||||||||||||||||||
211,682 | F | |||||||||||||||||||||||||||||||
62,639 | G | |||||||||||||||||||||||||||||||
12 | H | |||||||||||||||||||||||||||||||
(4,459 | ) | I | ||||||||||||||||||||||||||||||
38,034 | L | |||||||||||||||||||||||||||||||
— | N | |||||||||||||||||||||||||||||||
229 | O | |||||||||||||||||||||||||||||||
12,343 | P | |||||||||||||||||||||||||||||||
1,903 | Q | |||||||||||||||||||||||||||||||
(1,500 | ) | R | ||||||||||||||||||||||||||||||
Accumulated deficit |
(109,368 | ) | (4,459 | ) | 4,459 | I | (136,640 | ) | (136,640 | ) | ||||||||||||||||||||||
(276 | ) | L | ||||||||||||||||||||||||||||||
425 | C | |||||||||||||||||||||||||||||||
2,270 | K | |||||||||||||||||||||||||||||||
(1,903 | ) | Q | ||||||||||||||||||||||||||||||
(27,788 | ) | D | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total stockholders’ equity (deficit) |
(36,490 | ) | 5,000 | 434,313 | 402,823 | (211,684 | ) | 191,139 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total liabilities and stockholders’ equity (deficit) |
$ |
28,280 |
$ |
233,047 |
$ |
166,143 |
$ |
427,470 |
$ |
(211,684 |
) |
$ |
215,786 |
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
For the Six Months Ended June 30, 2021 |
Assuming No Redemptions |
Assuming Maximum Redemptions |
||||||||||||||||||||||||||
(In thousands, except share and per share data) | AEye (Historical) |
CF III (Historical) |
Transaction Accounting Adjustments |
Pro Forma Combined |
Transaction Accounting Adjustments |
Pro Forma Combined |
||||||||||||||||||||||
REVENUE: |
||||||||||||||||||||||||||||
Prototype sales and support |
$ | 461 | $ | 461 | $ | 461 | ||||||||||||||||||||||
Development contracts |
615 | 615 | 615 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total revenues |
1,076 | 1,076 | — | 1,076 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Cost of goods sold |
1,071 | 1,071 | 1,071 | |||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||
Gross profit |
5 | 5 | 5 | |||||||||||||||||||||||||
OPERATING EXPENSES: |
||||||||||||||||||||||||||||
Research and development |
11,562 | 11,562 | 11,562 | |||||||||||||||||||||||||
Sales and marketing |
3,498 | 3,498 | 3,498 | |||||||||||||||||||||||||
General and administrative |
7,760 | 1,035 | 951 | LL | 8,811 | 8,811 | ||||||||||||||||||||||
(510 | ) | NN | ||||||||||||||||||||||||||
(425 | ) | MM | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total operating expenses |
22,820 | 1,035 | 16 | 23,871 | — | 23,871 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
LOSS FROM OPERATIONS |
(22,815 | ) | (1,035 | ) | (16 | ) | (23,866 | ) | — | (23,866 | ) | |||||||||||||||||
OTHER INCOME (EXPENSE): |
||||||||||||||||||||||||||||
Change in fair value of embedded derivatives and warrants |
(119 | ) | (550 | ) | 119 | HH | (12 | ) | (12 | ) | ||||||||||||||||||
538 | KK | |||||||||||||||||||||||||||
PPP loan forgiveness |
2,297 | 2,297 | 2,297 | |||||||||||||||||||||||||
Interest income |
5 | 5 | 5 | |||||||||||||||||||||||||
Interest income on investment held in Trust Account |
11 | (11 | ) | GG | — | — | ||||||||||||||||||||||
Interest expense |
(1,952 | ) | 1,283 | JJ | (658 | ) | (658 | ) | ||||||||||||||||||||
|
|
|||||||||||||||||||||||||||
11 | II | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total other income (expense), net |
231 | (539 | ) | 1,940 | 1,632 | — | 1,632 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
NET (LOSS) |
$ | (22,584 | ) | $ | (1,574 | ) | $ | 1,924 | $ | (22,234 | ) | $ | — | $ | (22,234 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
PER SHARE DATA |
||||||||||||||||||||||||||||
Net loss per share (basic and diluted) |
$ | (2.08 | ) | |||||||||||||||||||||||||
Weighted average shares outstanding (basic and diluted) |
10,868,166 | |||||||||||||||||||||||||||
Net loss per share (basic and diluted), Class A - Public shares |
$ | — | $ | (0.13 | ) | $ | (0.15 | ) | ||||||||||||||||||||
Weighted average shares of Class A - Public shares |
23,000,000 | 173,971,236 | 153,012,383 | |||||||||||||||||||||||||
Net loss per share (basic and diluted), Class A - Private placement |
$ | (0.25 | ) | |||||||||||||||||||||||||
Weighted average shares of Class A - Private placement |
500,000 | |||||||||||||||||||||||||||
Net loss per share (basic and diluted), Class B - Common Stock |
$ | (0.25 | ) | |||||||||||||||||||||||||
Weighted average shares of Class B - Common stock |
5,750,000 |
For the Year Ended December 31, 2020 |
Assuming No Redemptions |
Assuming Maximum Redemptions |
||||||||||||||||||||||||||
(In thousands, except share and per share data) | AEye (Historical) |
CF III (Historical) |
Pro Forma Adjustments |
Pro Forma Combined |
Additional Pro Forma Adjustments |
Pro Forma Combined |
||||||||||||||||||||||
REVENUE: |
||||||||||||||||||||||||||||
Prototype sales and support |
$ | 365 | $ | 365 | $ | 365 | ||||||||||||||||||||||
Development contracts |
1,214 | 1,214 | 1,214 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total revenues |
$ | 1,579 | $ | 1,579 | $ | — | $ | 1,579 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Cost of goods sold |
808 | 808 | 808 | |||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||
Gross profit |
771 | 771 | 771 | |||||||||||||||||||||||||
OPERATING EXPENSES: |
||||||||||||||||||||||||||||
Research and development |
17,130 | 17,130 | 17,130 | |||||||||||||||||||||||||
Sales and marketing |
3,408 | 3,408 | 3,408 | |||||||||||||||||||||||||
General and administrative |
6,715 | 154 | 1,670 | FF | 8,539 | 8,539 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total operating expenses |
$ | 27,253 | $ | 154 | $ | 1,670 | $ | 29,077 | $ | — | $ | 29,077 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
LOSS FROM OPERATIONS |
(26,482 | ) | (154 | ) | (1,670 | ) | (28,306 | ) | — | (28,306 | ) | |||||||||||||||||
OTHER INCOME (EXPENSE): |
||||||||||||||||||||||||||||
Change in fair value of embedded derivatives and warrants |
1,410 | (2,730 | ) | (1,410 | ) | BB | (58 | ) | (58 | ) | ||||||||||||||||||
2,672 | EE | |||||||||||||||||||||||||||
Interest income |
23 | 23 | 23 | |||||||||||||||||||||||||
Interest income on investment held in Trust Account |
1 | (1 | ) | AA | — | — | ||||||||||||||||||||||
Interest expense |
(1,502 | ) | 1,185 | DD | (301 | ) | (301 | ) | ||||||||||||||||||||
16 | CC | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total other income (expense), net |
(69 | ) | (2,729 | ) | 2,462 | (336 | ) | — | (336 | ) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
NET LOSS |
$ | (26,551 | ) | $ | (2,883 | ) | $ | 792 | $ | (28,642 | ) | $ | — | $ | (28,642 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
PER SHARE DATA |
||||||||||||||||||||||||||||
Net loss per share (basic and diluted) |
$ | (2.36 | ) | |||||||||||||||||||||||||
Weighted average shares outstanding (basic and diluted) |
11,247,251 | |||||||||||||||||||||||||||
Net loss per share (basic and diluted), Class A - Public shares |
$ | — | $ | (0.16 | ) | $ | (0.19 | ) | ||||||||||||||||||||
Weighted average shares of Class A - Public shares |
23,000,000 | 173,614,708 | 152,288,934 | |||||||||||||||||||||||||
Net loss per share (basic and diluted), Class A - Private placement |
$ | (0.52 | ) | |||||||||||||||||||||||||
Weighted average shares of Class A - Private placement |
500,000 | |||||||||||||||||||||||||||
Net loss per share (basic and diluted), Class B - Common Stock |
$ | (0.52 | ) | |||||||||||||||||||||||||
Weighted average shares of Class B - Common stock |
5,090,659 |
1. |
BASIS OF PRESENTATION |
• | the (a) historical audited financial statements of CF III as of and for the year ended December 31, 2020 and (b) historical unaudited condensed financial statements of CF III as of and for the six months ended June 30, 2021; and |
• | the (a) historical audited consolidated financial statements of AEye as of and for the year ended December 31, 2020 and (b) historical unaudited condensed consolidated financial statements of AEye as of and for the six months ended June 30, 2021 |
2. |
ADJUSTMENTS TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION |
3. |
NET LOSS PER SHARE |
For the Six Months Ended June 30, 2021 |
For the Year Ended December 31, 2020 |
|||||||||||||||
Assuming No Redemptions |
Assuming Maximum Redemptions |
Assuming No Redemptions |
Assuming Maximum Redemptions |
|||||||||||||
Pro forma net loss |
$ | (22,234 | ) | $ | (22,234 | ) | $ | (28,642 | ) | $ | (28,642 | ) | ||||
Basic and diluted weighted average shares outstanding |
173,971,236 | 153,012,383 | 173,614,708 | 152,288,934 | ||||||||||||
Pro forma net loss per share - basic and diluted |
$ | (0.13 | ) | $ | (0.15 | ) | $ | (0.16 | ) | $ | (0.19 | ) | ||||
Pro forma weighted average shares outstanding - basic and diluted |
||||||||||||||||
Former CF III Class A stockholders |
23,000,000 | 2,041,147 | 23,000,000 | 1,674,226 | ||||||||||||
Former CF III Class B stockholders |
5,750,000 | 5,750,000 | 5,750,000 | 5,750,000 | ||||||||||||
Class A Common Stock purchased by Sponsor in the Private Placement |
500,000 | 500,000 | 500,000 | 500,000 | ||||||||||||
Former AEye Stockholders (including holders of AEye Preferred Stock) and holders of AEye Convertible Equity Instruments |
122,221,236 | 122,221,236 | 121,864,708 | 121,864,708 | ||||||||||||
PIPE Investors |
22,500,000 | 22,500,000 | 22,500,000 | 22,500,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
173,971,236 | 153,012,383 | 173,614,708 | 152,288,934 | |||||||||||||
|
|
|
|
|
|
|
|
AEye Options that will convert into a right to purchase shares of Class A Common Stock |
7,995,503 | |||
AEye Warrants that will convert into a right to purchase shares of Class A Common Stock |
64,721 | |||
|
|
|||
Total |
8,060,224 |
• | personnel-related expenses, including salaries, benefits, bonuses, and stock-based compensation expense; |
• | third-party engineering and contractor costs; |
• | new hardware and software expenses; and |
• | allocated overhead expenses. |
Years Ended December 31, | Variance | |||||||||||||||
(in thousands, except percentages) | 2020 |
2019 |
$ |
% |
||||||||||||
Prototype sales |
$ | 365 | $ | 291 | $ | 74 | 25.4 | % | ||||||||
Development contracts |
1,214 | 1,175 | 39 | 3.3 | % | |||||||||||
Total revenues |
1,579 | 1,466 | 113 | 7.7 | % | |||||||||||
Cost of revenue |
808 | 253 | 555 | 219.4 | % | |||||||||||
Gross profit |
771 | 1,213 | (442 | ) | (36.4 | )% | ||||||||||
Research and development |
17,130 | 18,661 | (1,531 | ) | (8.2 | )% | ||||||||||
Sales and marketing |
3,408 | 4,244 | (836 | ) | (19.7 | )% | ||||||||||
General and administrative |
6,715 | 7,129 | (414 | ) | (5.8 | )% | ||||||||||
Total operating expenses |
27,253 | 30,034 | (2,781 | ) | (9.3 | )% | ||||||||||
Loss from operations |
(26,482 | ) | (28,821 | ) | (2,339 | ) | (8.1 | )% | ||||||||
Change in fair value of embedded derivative liability and warrant liability |
1,410 | — | 1,410 | N/A | ||||||||||||
Interest income |
23 | 266 | (243 | ) | (91.4 | )% | ||||||||||
Interest expense |
(1,502 | ) | (96 | ) | (1,406 | ) | 1,464.6 | % | ||||||||
Total other income/(expense), net |
(69 | ) | 170 | (239 | ) | (140.6 | )% | |||||||||
Net loss |
$ | (26,551 | ) | $ | (28,651 | ) | $ | (2,100 | ) | (7.3 | )% |
Six Months Ended June 30, |
Variance | |||||||||||||||
2021 |
2020 |
$ |
% |
|||||||||||||
(in thousands, except percentages) | ||||||||||||||||
Prototype sales |
$ | 461 | $ | 63 | $ | 398 | 631.7 | % | ||||||||
Development contracts |
615 | 100 | 515 | 515.0 | % | |||||||||||
Total revenues |
1,076 | 163 | 913 | 560.1 | % | |||||||||||
Cost of revenue |
1,071 | 147 | 924 | 628.6 | % | |||||||||||
Gross Profit |
5 | 16 | (11 | ) | (68.8 | )% | ||||||||||
Research and development |
11,562 | 7,960 | 3,602 | 45.3 | % | |||||||||||
Sales and marketing |
3,498 | 1,938 | 1,560 | 80.5 | % | |||||||||||
General and administrative |
7,760 | 3,212 | 4,548 | 141.6 | % | |||||||||||
Total operating expenses |
22,820 | 13,110 | 9,710 | 74.1 | % | |||||||||||
Loss from operations |
(22,815 | ) | (13,094 | ) | (9,721 | ) | 74.2 | % | ||||||||
Change in fair value of embedded derivative liability and warrant liability |
(119 | ) | (82 | ) | (37 | ) | 45.1 | % | ||||||||
PPP loan forgiveness |
2,297 | — | 2,297 | 100.0 | % | |||||||||||
Interest income |
5 | 13 | (8 | ) | (61.5 | )% | ||||||||||
Interest expense |
(1,952 | ) | (554 | ) | (1,398 | ) | 252.3 | % | ||||||||
Total other income/(expense), net |
231 | (623 | ) | 854 | (137.1 | )% | ||||||||||
Net loss |
$ | (22,584 | ) | $ | (13,717 | ) | $ | (8,867 | ) | 64.6 | % |
Six months ended June 30, |
||||||||
2021 |
2020 |
|||||||
(in thousands) |
||||||||
Net cash provided by (used in): |
||||||||
Operating activities |
$ | (18,339 | ) | $ | (10,005 | ) | ||
Investing activities |
$ | (245 | ) | $ | (3,914 | ) | ||
Financing activities |
$ | 15,463 | $ | 12,229 |
Less than 1 year |
1 to 3 years |
3 to 5 years |
More than 5 years |
|||||||||||||
Rental Payments |
$ | 2,317 | $ | 4,703 | $ | 4,969 | $ | 1,063 | ||||||||
Convertible Notes |
$ | 37,759 | — | — | — | |||||||||||
Borrowings - net of issuance costs |
$ | 11,334 | $ | 1,242 | ||||||||||||
Total |
$ | 51,410 | $ | 5,945 | $ | 4,969 | $ | 1,063 |
• | the results of contemporaneous valuations performed at periodic intervals by an independent valuation firm; |
• | the prices, rights, preferences, and privileges of our convertible preferred stock relative to those of our AEye Common Stock; |
• | the prices of our convertible preferred stock and AEye Common Stock sold to investors in arms-length transactions or offered to investors through a tender offer; |
• | our actual operating and financial performance and estimated trends and prospects for our future performance; |
• | our stage of development; |
• | the likelihood of achieving a liquidity event, such as an initial public offering, merger with a SPAC, direct listing, or sale of our company, given prevailing market conditions; |
• | the lack of marketability involving securities in a private company; |
• | the market performance of comparable publicly traded companies; and |
• | U.S. and global capital market conditions and overall economic conditions. |
• | Passenger vehicle ADAS systems |
• | Commercial vehicle ADAS systems |
• | Shuttles |
• | Logistics |
• | Delivery |
• | Rail |
• | Construction, Mining &Agriculture |
• | Aerospace & Defense |
• | Drones |
• | Traffic Systems |
(1) |
iDAR at Design: |
(2) |
Triggered iDAR: |
(3) |
Responsive iDAR: |
(4) |
Predictive iDAR: |
• | Active lidar enables user’s choice of deterministic scan patterns catered to specific use cases and applications, such as highway autopilot; |
• | Feature-specific Fixed Regions of Interest (ROIs) designed to detect threats from various locations; |
• | Lidar perception made available through a software reference library; |
• | Windshield, grill, and other discreet vehicle integration options that are optimized by software configurability; |
• | Size, Weight and Power (“SWaP”) optimized; |
• | Functional Safety (“FuSa”)/Safety of the Intended Functionality (“SOTIF” or ISO 21448) compliant for signal path — providing necessary determinism for testing and validation; |
• | Lower cost than other long range lidar for ADAS applications with similar start of production date. |
Name |
Age |
Position | ||
Blair LaCorte | 58 | Chief Executive Officer and Director | ||
Luis Dussan | 46 | Chief Technology Officer, Chief Product Strategist and Director | ||
Robert Brown | 56 | Treasurer, Chief Financial Officer and Chief Accounting Officer | ||
Thomas R. Tewell | 54 | Chief Operating Officer | ||
Andrew S. Hughes | 55 | Secretary and General Counsel | ||
Wen Hsieh | 48 | Director | ||
Prof. Dr. Bernd Gottschalk | 77 | Director | ||
Dr. Karl-Thomas Neumann | 60 | Director | ||
Timothy J. Dunn | 63 | Director | ||
Carol DiBattiste | 69 | Director |
• | Blair LaCorte, our Chief Executive Officer |
• | Luis Dussan, our Chief Technology Officer and founder |
• | Robert Brown, Chief Financial Officer |
Element |
Purpose | |
Base Salary |
Recognize performance of job responsibilities and attract and retain individuals with superior talent. | |
Discretionary Cash Bonus |
Incentivize and reward employees for contributions to Company performance. | |
Equity Compensation |
Promote an employee ownership culture and the maximization of long-term stockholder value by aligning the interests of employees and stockholders | |
Perquisites |
We generally provide benefits to our named executive officers on the same basis as provided to all of our employees, including 100% contribution by us towards medical, dental and vision insurance and a tax-qualified Section 401(k) plan, including a safe harbor matching contribution by us of 100% on the first 3% of eligible compensation contributed and 50% of the following 2% eligible compensation contributed annually. Our NEOs are, however, reimbursed up to $10,000 annually for executive medical services (a benefit not available to other employees). |
Name and principal position |
Fiscal Year |
Salary ($) |
Option Awards ($) (3) |
Bonus ($) (4) |
All Other Compensation ($) (5) |
Total ($) |
||||||||||||||||||
Blair LaCorte |
2020 | $ | 218,506 | $ | 4,225,476 | 0 | $ | 19,530.00 | $ | 4,463,512 | ||||||||||||||
Chief Executive Officer |
2019 | $ | 230,417 | $ | 153,120 | 0 | $ | 4,423.00 | $ | 387,960 | ||||||||||||||
Luis Dussan |
2020 | $ | 236,699 | 0 | (1) |
0 | $ | 24,444 | $ | 261,143 | ||||||||||||||
Chief Technology Officer and founder |
2019 | $ | 300,000 | 0 | (1) |
0 | $ | 14,269 | $ |
314,269 |
||||||||||||||
Robert Brown (2) |
2020 | $ | 18,750 | $ | 2,043,161 | 0 | 0 | $ |
2,061,911 |
|||||||||||||||
Chief Financial Officer |
2019 | n/a | n/a | n/a | n/a |
(1) | Received stock option grants but they were terminated in connection with transitioning from the role of CEO to the role of President and Chief Technology Officer of AEye. |
(2) | Robert Brown joined AEye in November 2020. |
(3) | Reflects options granted under AEye’s 2016 Incentive Plan, determined with reference to a fair market value of a share of common stock in the 2019 calendar year of $2.32 and $2.33 in 2020. |
(4) | Reflects any discretionary cash bonuses paid. |
(5) | Amounts reported under “All Other Compensation” reflect employer contributions made pursuant to AEye’s 401(k) plan for each NEO and any stipends received. |
• | the individual’s anticipated responsibilities and experience; |
• | its directors’ collective experience and knowledge in compensating similarly situated individuals at other companies; and |
• | the value of the executive officer’s existing equity awards. |
• | All stock options and SARs held by the participant which were exercisable immediately prior to the participant’s termination of service with us other than for Cause (as defined in the Incentive Plan) will, except as otherwise set forth in the option award agreement, remain exercisable for the lesser of (i) three (3) months or (ii) the period ending on the latest date such stock option or SAR could have been exercised; |
• | All stock options and SARs held by the participant which were exercisable immediately prior to the participant’s termination of service with us due to death will remain exercisable for the lesser of (i) the |
one-year period ending with the first anniversary of the participant’s termination or (ii) the period ending on the latest date on which such stock option or SAR could have been exercised (provided that a participant’s service will be deemed to have terminated due to death if the participant dies within three (3) months (or such other period provided by the participant’s award agreement) after the participant’s termination of service); and |
• | All stock options and SARs held by a participant which were exercisable immediately prior to the participant’s termination of service with us due to Disability (as defined in the Incentive Plan) will remain exercisable for the lesser of (i) the one (1) year period ending with the first anniversary of the participant’s termination or (ii) the period ending on the latest date on which such stock option or SAR could have been exercised. |
(i) | any “person” becomes the “beneficial owner”, directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total fair market value or total combined voting power of the Company’s then-outstanding securities entitled to vote generally in the election of directors; provided, however, that a Change in Control shall not be deemed to have occurred if such degree of beneficial ownership results from any of the following: (A) an acquisition by any person who on the effective date is the beneficial owner of more than fifty percent (50%) of such voting power, (B) any acquisition directly from the Company, including, without limitation, pursuant to or in connection with a public offering of securities, (C) any acquisition by the Company, (D) any acquisition by a trustee or other fiduciary under an employee benefit plan of a participating company or (E) any acquisition by an entity owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the voting securities of the Company; or |
(ii) | a transaction in which the stockholders of the Company immediately before the transaction do not retain immediately after the transaction direct or indirect beneficial ownership of more than fifty percent (50%) of the total combined voting power of the outstanding securities entitled to vote generally in the election of directors; or |
(iii) | a date specified by the “committee” following approval by the stockholders of a plan of complete liquidation or dissolution of the Company; |
Option Awards |
||||||||||||||||||||
Name |
Grant Date |
Number of Securities Underlying Unexercised Options (#) Exercisable |
Number of Securities Underlying Unexercised Options (#) Unexercisable |
Option Exercise Price ($) |
Option Expiration Date |
|||||||||||||||
Blair LaCorte |
06/01/2017 | (1) |
— | 20,843 | 0.59 | 05/31/2027 | ||||||||||||||
Chief Executive Officer and Director |
05/08/2018 | (2) |
— | 5,209 | 0.65 | 05/07/2028 | ||||||||||||||
09/18/2018 | (3) |
— | 8,568 | 0.65 | 09/17/2028 | |||||||||||||||
02/28/2019 | (4) |
— | 29,167 | 2.32 | 02/27/2029 | |||||||||||||||
07/02/2019 | (5) |
— | 5,625 | 2.32 | 07/01/2029 | |||||||||||||||
04/10/2020 | (6) |
2,469 | 5,723 | 2.33 | 04/09/2030 | |||||||||||||||
10/01/2020 | (7) |
399,085 | 1,347,257 | 2.33 | 09/30/2030 | |||||||||||||||
Robert Brown |
11/17/2020 | (8) |
— | 876,893 | 2.33 | 11/16/2030 | ||||||||||||||
Chief Financial Officer |
(1) | 1/48 of the shares underlying the award vest each month from the vesting commencement date, May 29, 2017. 50% percent of the unvested shares subject to the award will immediately vest if Mr. LaCorte is terminated without “cause” within 12 months of a “change in control.” |
(2) | 1/48 of the shares underlying the award vest each month from the vesting commencement date, May 29, 2017. |
(3) | 1/48 of the shares underlying the award vest each month from the vesting commencement date, September 18, 2018. |
(4) | 1/48 of the shares underlying the award vest each month from the vesting commencement date, January 1, 2019. |
(5) | 1/48 of the shares underlying the award vest each month from the vesting commencement date, March 18, 2019. |
(6) | 1/12 of the shares underlying the award vest each month from the vesting commencement date, April 4, 2020. |
(7) | 1/48 of the shares underlying the award vest each month from the vesting commencement date, December 12, 2019. 100% of the unvested shares subject to the award will immediately vest if Mr. LaCorte is terminated without “cause” within 12 months of a “change in control”. |
(8) | 25% of the shares underlying the reward vest on the one-year anniversary of the vesting commencement date, November 16, 2020; thereafter, 1/48 of the shares underlying the award vest each month. 25% of the unvested shares subject to the award will immediately vest if AEye experiences a “change in control and Mr. Brown is terminated without “cause” on or before November 16, 2021. 25% of the shares subject to the award will immediately vest upon the successful completion of the Merger on or before November 16, 2021. |
• | we, Old AEye or CF III have been or are to be a participant; |
• | the amount involved exceeds or will exceed $120,000; and |
• | any of our directors, executive officers or beneficial holders of more than 5% of our capital stock, or any immediate family member of, or person sharing the household with, any of these individuals (other than tenants or employees), had or will have a direct or indirect material interest. |
Name |
Aggregate Principal Amount |
|||
KPCB Holdings, Inc., as nominee |
$ | 7,344,919.15 | ||
Taiwania Capital Buffalo Fund Co., Ltd. |
$ | 1,973,729.03 | ||
General Motors Ventures LLC |
$ | 2,844,199.15 |
(1) | Wen Hsieh is a member of the AEye Board and is affiliated with KPCB Holdings, Inc., as nominee. KPCB Holdings, Inc. as nominee holds more than 5% of AEye Common Stock. |
(2) | Huang Lee is a former member of the AEye Board and is affiliated with Taiwania Capital Buffalo Fund Co., Ltd. |
(3) | General Motors Ventures LLC holds more than 5% of AEye Common Stock. |
Stockholder |
Shares of Series A Preferred Stock |
Total Purchase Price |
Total Principal and Accrued Interest on Convertible Note |
|||||||||
General Motors Ventures LLC |
2,448,220 | 5,000,000 | n/a | |||||||||
KPCB Holdings, Inc., as nominee |
2,448,220 | $ | 5,000,000 | n/a |
(1) | General Motors Ventures LLC holds more than 5% of AEye capital stock. |
(2) | Wen Hsieh is a member of the AEye Board and is affiliated with KPCB Holdings, Inc. as nominee. KPCB Holdings, Inc., as nominee holds more than 5% of AEye capital stock. |
Stockholder |
Shares of Series B Preferred Stock |
Total Purchase Price |
Series B Preferred Shares from Conversion of Notes |
Total Principal on Convertible Note |
||||||||||||
Taiwania Capital Buffalo Fund Co., Ltd |
1,130,436 | $ | 6,999,998.85 | N/A | N/A | |||||||||||
General Motors Ventures LLC |
391,146 | $ | 2,422,093.38 | 462,564 | $ | 2,577,905.00 | ||||||||||
KPCB Holdings, Inc., as nominee |
391,146 | $ | 2,422,093.38 | 462,564 | $ | 2,577,905.00 | ||||||||||
HELLA Ventures LLC |
540,993 | 3,349,990.95 | 296,066 | 1,650,000 |
(1) | Huang Lee is a former member of the AEye Board and is affiliated with Taiwania Capital Buffalo Fund Co., Ltd. |
(2) | General Motors Ventures LLC holds more than 5% of AEye capital stock. |
(3) | Wen Hsieh is a member of the AEye Board and is affiliated with KPCB Holdings, Inc. as nominee. KPCB Holdings, Inc., as nominee holds more than 5% of AEye capital stock. |
(4) | HELLA Ventures LLC is holding more than 5% of AEye capital stock. |
• | each person known by the Company to be the beneficial owner of more than five percent (5%) of the outstanding shares of the Company’s Common Stock; |
• | each current executive officer and director of the Company; and |
• | all current executive officers and directors of the Company, as a group. |
Name and Address of Beneficial Owner |
Number of Shares |
% of Class |
||||||
Directors and Executive Officers(1) |
||||||||
Blair LaCorte(2) |
4,482,507 | 2.8 | % | |||||
Luis Dussan(3) |
18,324,105 | 11.8 | % | |||||
Robert Brown(4) |
821,884 | * | ||||||
Thomas R. Tewell |
— | * | ||||||
Andrew S. Hughes |
— | * | ||||||
Wen Hsieh |
— | * | ||||||
Prof. Dr. Bernd Gottschalk(5) |
37,208 | * | ||||||
Dr. Karl-Thomas Neumann(6) |
2,478 | * | ||||||
Timothy J. Dunn(7) |
17,052 | * | ||||||
Carol DiBattiste(8) |
9,302 | * | ||||||
All directors and officers as a group(10 individuals) |
23,694,540 | 15.2 | % | |||||
5% Shareholders |
||||||||
KPCB Holdings, Inc., as nominee(9) |
16,300,697 | 10.5 | % | |||||
General Motors Ventures LLC(10) |
13,864,191 | 8.9 | % |
* | Less than one percent. |
(1) | Unless otherwise noted, the business address of each of the following individuals or entities is c/o AEye, Inc., 1 Park Place, Suite 200, Dublin, CA 94568. |
(2) | Interests shown consist of (a) 1,405,484 shares of Common Stock and (b) options to purchase 3,077,023 shares of Common Stock that are exercisable within 60 days of August 16, 2021. |
(3) | Interests shown consist of (a) 18,316,664 shares of Common Stock and (b) options to purchase 7,441 shares of Common Stock that are exercisable within 60 days of August 16, 2021. |
(4) | Interests shown consist of options to purchase 821,884 shares of Common Stock that are exercisable within 60 days of August 16, 2021. |
(5) | Interests shown consist of options to purchase 37,208 shares of Common Stock that are exercisable within 60 days of August 16, 2021. |
(6) | Interests shown consist of options to purchase 2,478 shares of Common Stock that are exercisable within 60 days of August 16, 2021. |
(7) | Interests shown consist of options to purchase 17,052 shares of Common Stock that are exercisable within 60 days of August 16, 2021. |
(8) | Interests shown consist of options to purchase 9,302 shares of Common Stock that are exercisable within 60 days of August 16, 2021. |
(9) | Consists of (a) 13,405,167 shares of our common stock held by Kleiner Perkins Caufield & Byers XVI, LLC (“KPCB XVI”), 458,898 shares held by KPCB XVI Founders Fund, LLC (“XVI Founders”), 2,362,303 shares held by Kleiner Perkins Caufield & Byers XIX, LLC (“KPCB XIX”), 22,179 shares held by Kleiner Perkins XIX Friends, LLC (“XIX Friends”) and 52,150 shares held by KPCB XIX Founders Fund, LLC (“XIX Founders”). All shares are held for convenience in the name of “KPCB Holdings, Inc., as nominee” for the accounts of such individuals and entities. The managing member of KPCB XVI and XVI Founders is KPCB XVI Associates, LLC (“KPCB XVI Associates”). L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI and XVI Founders. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI and XVI Founders except to the extent of their pecuniary interest therein. The managing member of KPCB XIX, XIX Friends and XIX Founders is KPCB XIX Associates, LLC (“KPCB XIX Associates”). Ilya Fushman, Mamoon Hamid and Wen Hsieh, the managing members of KPCB XIX Associates, exercise shared voting and dispositive control over the shares held by KPCB XIX, XIX Friends and XIX Founders. Such managing members disclaim beneficial ownership of all shares held by KPCB XIX, XIX Friends and XIX Founders except to the extent of their pecuniary interest therein. The principal business address for all entities and individuals affiliated with Kleiner Perkins Caufield & Byers is c/o Kleiner Perkins Caufield & Byers, LLC, 2750 Sand Hill Road, Menlo Park, CA 94025. |
(10) | The business address of General Motors Ventures LLC is MC 482-C37-D99, 300 Renaissance Center, Detroit, MI 48265. |
Names and Addresses |
Securities Beneficially Owned prior to this Offering |
Securities to be Sold in this Offering |
Securities Beneficially Owned after this Offering |
|||||||||||||||||||||||||||||
Shares of Common Stock |
Warrants |
Shares of Common Stock |
Warrants |
Shares of Common Stock |
Percentage |
Warrants |
Percentage |
|||||||||||||||||||||||||
ADB Holdings I LLC (1) |
293,795 | — | 293,795 | — | — | — | — | — | ||||||||||||||||||||||||
Arena Capital Fund, LP - Series 4 (2) |
150,000 | — | 150,000 | — | — | — | — | — | ||||||||||||||||||||||||
Arena Capital Fund, LP - Series 6 (2) |
150,000 | — | 150,000 | — | — | — | — | — | ||||||||||||||||||||||||
Arena Capital Fund, LP - Series 9 (2) |
175,000 | — | 175,000 | — | — | — | — | — | ||||||||||||||||||||||||
Arena Capital Fund, LP - Series 14 (2) |
25,000 | — | 25,000 | — | — | — | — | — | ||||||||||||||||||||||||
Aristeia Capital, L.L.C (3) |
700,000 | — | 700,000 | — | — | — | — | — | ||||||||||||||||||||||||
Atman Fund II LP |
200,000 | — | 200,000 | — | — | — | — | — |
Names and Addresses |
Securities Beneficially Owned prior to this Offering |
Securities to be Sold in this Offering |
Securities Beneficially Owned after this Offering |
|||||||||||||||||||||||||||||
Shares of Common Stock |
Warrants |
Shares of Common Stock |
Warrants |
Shares of Common Stock |
Percentage |
Warrants |
Percentage |
|||||||||||||||||||||||||
BEMAP Master Fund Ltd. |
129,461 | — | 129,461 | — | — | — | — | — | ||||||||||||||||||||||||
Beryl Capital Partners II LP |
167,735 | — | 167,735 | — | — | — | — | — | ||||||||||||||||||||||||
Beryl Capital Partners LP |
13,770 | — | 13,770 | — | — | — | — | — | ||||||||||||||||||||||||
Blair LaCorte (4)(5) |
4,482,507 | — | 4,482,507 | — | ||||||||||||||||||||||||||||
Bespoke Alpha MAC MIM LP |
16,760 | — | 16,760 | — | — | — | — | — | ||||||||||||||||||||||||
Blackstone Aqua Master Sub-Fund, a sub-fund of Blackstone Global MasterFund ICAV (6) |
1,200,000 | — | 1,200,000 | — | — | — | — | — | ||||||||||||||||||||||||
Blackwell Partners LLC - Series A (7) |
275,000 | — | 275,000 | — | — | — | — | — | ||||||||||||||||||||||||
Castle Hook Master Fund Ltd. (8) |
1,000,000 | — | 1,000,000 | — | — | — | — | — | ||||||||||||||||||||||||
CF Finance Holdings III, LLC (4)(9) |
4,426,000 | 166,666 | 4,426,000 | 166,666 | — | — | — | — | ||||||||||||||||||||||||
Citadel Multi-Strategy Equities Master Fund Ltd. (10) |
575,814 | — | 500,000 | — | 75,814 | * | — | — | ||||||||||||||||||||||||
Context Partners Master Fund, L.P. (11) |
400,000 | — | 400,000 | — | — | — | — | — | ||||||||||||||||||||||||
Continental Automotive Systems, Inc. |
450,000 | — | 450,000 | — | — | — | — | — | ||||||||||||||||||||||||
Cooper Road Acquisition, LLC (12) |
100,832 | — | 100,832 | — | — | — | — | — | ||||||||||||||||||||||||
Cooper Road, LLC (13) |
838,378 | — | 838,378 | — | — | — | — | — | ||||||||||||||||||||||||
Corbin Hedged Equity Fund LP |
13,372 | — | 13,372 | — | — | — | — | — | ||||||||||||||||||||||||
Dean Kehler |
939,210 | — | 939,210 | — | — | — | — | — | ||||||||||||||||||||||||
Dominant Capital Limited |
400,000 | — | 400,000 | — | — | — | — | — | ||||||||||||||||||||||||
DS Liquid Div RVA MON LLC |
156,162 | — | 156,162 | — | — | — | — | — | ||||||||||||||||||||||||
ECMC Group, Inc. (14) |
900,000 | — | 900,000 | — | — | — | — | — | ||||||||||||||||||||||||
Gain Global Co., Ltd. |
625,000 | — | 625,000 | — | — | — | — | — | ||||||||||||||||||||||||
General Motors Ventures LLC (15) |
200,000 | — | 200,000 | — | — | — | — | — | ||||||||||||||||||||||||
Grandwin Enterprises Limited (16) |
100,000 | — | 100,000 | — | — | — | — | — | ||||||||||||||||||||||||
HELLA Ventures LLC |
200,000 | — | 200,000 | — | — | — | — | — | ||||||||||||||||||||||||
Hillel Weinberger |
104,579 | — | 104,579 | — | — | — | — | — | ||||||||||||||||||||||||
Integrated Core Strategies (US) LLC (17) |
800,000 | 205,755 | 800,000 | 205,755 | — | — | 205,755 | * | ||||||||||||||||||||||||
Intel Capital Corporation |
250,000 | — | 250,000 | — | — | — | — | — | ||||||||||||||||||||||||
Jason Capone |
104,579 | — | 104,579 | — | — | — | — | — | ||||||||||||||||||||||||
Jordan Bloom |
195,864 | — | 195,864 | — | — | — | — | — | ||||||||||||||||||||||||
Kepos Alpha Master Fund L.P. (18) |
400,000 | — | 400,000 | — | — | — | — | — |
Names and Addresses |
Securities Beneficially Owned prior to this Offering |
Securities to be Sold in this Offering |
Securities Beneficially Owned after this Offering |
|||||||||||||||||||||||||||||
Shares of Common Stock |
Warrants |
Shares of Common Stock |
Warrants |
Shares of Common Stock |
Percentage |
Warrants |
Percentage |
|||||||||||||||||||||||||
KPCB Holdings, Inc., as nominee (4)(19) |
16,300,697 | — | 16,300,697 | — | ||||||||||||||||||||||||||||
LCT18 Investments, LLC |
100,000 | — | 100,000 | — | — | — | — | — | ||||||||||||||||||||||||
Leon Wagner |
104,579 | — | 104,579 | — | — | — | — | — | ||||||||||||||||||||||||
Linden Capital L.P. (20) |
500,000 | — | 500,000 | — | — | — | — | — | ||||||||||||||||||||||||
Lionhill Ventures Limited |
40,000 | — | 40,000 | — | — | — | — | — | ||||||||||||||||||||||||
Liu Lin |
200,000 | — | 200,000 | — | — | — | — | — | ||||||||||||||||||||||||
Long Wang |
200,000 | — | 200,000 | — | — | — | — | — | ||||||||||||||||||||||||
Luis Dussan (4)(21) |
18,324,105 | — | 18,324,105 | — | ||||||||||||||||||||||||||||
Lugard Road Capital Master Fund, LP (22) |
394,039 | — | 394,039 | — | — | — | — | — | ||||||||||||||||||||||||
Luxor Capital Partners Offshore Master Fund, LP (23) |
1,991 | — | 1,991 | — | — | — | — | — | ||||||||||||||||||||||||
Luxor Capital Partners, LP (24) |
3,178 | — | 3,178 | — | — | — | — | — | ||||||||||||||||||||||||
Luxor Wavefront, LP (25) |
792 | — | 792 | — | — | — | — | — | ||||||||||||||||||||||||
Magnetar Capital Master Fund Ltd. |
25,000 | — | 25,000 | — | — | — | — | — | ||||||||||||||||||||||||
Magnetar Constellation Fund II, Ltd. |
50,000 | — | 50,000 | — | — | — | — | — | ||||||||||||||||||||||||
Magnetar Constellation Master Fund, Ltd. |
167,000 | — | 167,000 | — | — | — | — | — | ||||||||||||||||||||||||
Magnetar Discovery Master Fund Ltd. |
20,000 | — | 20,000 | — | — | — | — | — | ||||||||||||||||||||||||
Magnetar Lake Credit Fund LLC |
25,000 | — | 25,000 | — | — | — | — | — | ||||||||||||||||||||||||
Magnetar Longhorn Fund LP |
19,000 | — | 19,000 | — | — | — | — | — | ||||||||||||||||||||||||
Magnetar SC Fund Ltd. |
38,000 | — | 38,000 | — | — | — | — | — | ||||||||||||||||||||||||
Magnetar Structured Credit Fund, LP |
67,000 | — | 67,000 | — | — | — | — | — | ||||||||||||||||||||||||
Magnetar Xing He Master Fund Ltd. |
58,000 | — | 58,000 | — | — | — | — | — | ||||||||||||||||||||||||
Marc Mazur |
10,458 | — | 10,458 | — | — | — | — | — | ||||||||||||||||||||||||
Maso Capital Investments Limited |
100,000 | — | 100,000 | — | — | — | — | — | ||||||||||||||||||||||||
Michael Maselli |
391,726 | — | 391,726 | — | — | — | — | — | ||||||||||||||||||||||||
Millais Limited |
400,000 | — | 400,000 | — | — | — | — | — | ||||||||||||||||||||||||
MMCAP International Inc. SPC (26) |
400,000 | — | 400,000 | — | — | — | — | — | ||||||||||||||||||||||||
MMF LT, LLC (27) |
500,000 | — | 500,000 | — | — | — | — | — | ||||||||||||||||||||||||
Monashee Pure Alpha SPV I LP |
76,946 | — | 76,946 | — | — | — | — | — | ||||||||||||||||||||||||
Monashee Solitario Fund LP |
98,701 | — | 98,701 | — | — | — | — | — | ||||||||||||||||||||||||
Noble Delight Enterprises Corp. |
500,000 | — | 500,000 | — | — | — | — | — | ||||||||||||||||||||||||
Norwich Assets Limited (28) |
100,000 | — | 100,000 | — | — | — | — | — |
Names and Addresses |
Securities Beneficially Owned prior to this Offering |
Securities to be Sold in this Offering |
Securities Beneficially Owned after this Offering |
|||||||||||||||||||||||||||||
Shares of Common Stock |
Warrants |
Shares of Common Stock |
Warrants |
Shares of Common Stock |
Percentage |
Warrants |
Percentage |
|||||||||||||||||||||||||
Patriot Capital Limited (29) |
25,000 | — | 25,000 | — | — | — | — | — | ||||||||||||||||||||||||
Pinehurst Partners LP |
5,123 | — | 5,123 | — | — | — | — | — | ||||||||||||||||||||||||
Polar Long/Short Master Fund |
232,716 | — | 232,716 | — | — | — | — | — | ||||||||||||||||||||||||
Polar Multi-Strategy Master Fund |
167,284 | — | 167,284 | — | — | — | — | — | ||||||||||||||||||||||||
Purpose Alternative Credit Fund - T LLC |
8,000 | — | 8,000 | — | — | — | — | — | ||||||||||||||||||||||||
Purpose Alternative Credit Fund Ltd. |
23,000 | — | 23,000 | — | — | — | — | — | ||||||||||||||||||||||||
Ratan Capital Master Fund Ltd. |
300,000 | — | 300,000 | — | — | — | — | — | ||||||||||||||||||||||||
Robert Brown (4)(30) |
821,884 | — | 821,884 | — | ||||||||||||||||||||||||||||
Saba Capital Master Fund III, L.P. |
65,179 | — | 65,179 | — | — | — | — | — | ||||||||||||||||||||||||
Saba Capital Master Fund, Ltd. |
170,887 | — | 170,887 | — | — | — | — | — | ||||||||||||||||||||||||
Saba II AIV LP |
463,934 | — | 463,934 | — | — | — | — | — | ||||||||||||||||||||||||
SFL SPV I LLC |
21,970 | — | 21,970 | — | — | — | — | — | ||||||||||||||||||||||||
Spring Creek Capital, LLC (31) |
1,000,000 | — | 1,000,000 | — | — | — | — | — | ||||||||||||||||||||||||
Star V Partners LLC |
125,000 | — | 125,000 | — | — | — | — | — | ||||||||||||||||||||||||
Stonehaven Ventures Limited ( 32) |
60,000 | — | 60,000 | — | — | — | — | — | ||||||||||||||||||||||||
SUBARU-SBI Innovation Fund |
100,000 | — | 100,000 | — | — | — | — | — | ||||||||||||||||||||||||
Taiwania Capital Buffalo Fund Co., Ltd. |
100,000 | — | 100,000 | — | — | — | — | — | ||||||||||||||||||||||||
Tech Opportunities LLC (33) |
400,000 | — | 400,000 | — | — | — | — | — | ||||||||||||||||||||||||
The Cui Family Revocable Living Trust |
200,000 | — | 200,000 | — | — | — | — | — | ||||||||||||||||||||||||
The Joseph S. Lacob Revocable Trust created UTA dated July 19, 2007, as amended |
100,000 | — | 100,000 | — | — | — | — | — | ||||||||||||||||||||||||
Thomas V. Ward III |
25,000 | — | 25,000 | — | — | — | — | — | ||||||||||||||||||||||||
Thoth Investment Holdings Limited |
300,000 | — | 300,000 | — | — | — | — | — | ||||||||||||||||||||||||
Entities affiliated with TPG Public Equity Partners (34) |
1,500,000 | — | 1,500,000 | — | — | — | — | — | ||||||||||||||||||||||||
Tyche Partners II, L.P. |
100,000 | — | 100,000 | — | — | — | — | — | ||||||||||||||||||||||||
Tyler Engh |
25,000 | — | 25,000 | — | — | — | — | — | ||||||||||||||||||||||||
VMS Investment Group Limited |
200,000 | — | 200,000 | — | — | — | — | — | ||||||||||||||||||||||||
Wong Fung |
750,000 | — | 750,000 | — | — | — | — | — | ||||||||||||||||||||||||
Yi-Hua Chung |
200,000 | — | 200,000 | — | — | — | — | — | ||||||||||||||||||||||||
Zhao Kai |
350,000 | — | 350,000 | — | — | — | — | — |
* | less than 1% |
(1) | ADB Holdings I LLC is an entity controlled by Arthur D. Baer. |
(2) | Arena Capital Advisors manages such entity as the General Partner for Arena Capital Fund, LP. The address of such entity is 12121 Wilshire Blvd Suite 1010, Los Angeles, CA 90025. |
(3) | Aristeia Capital, L.L.C. and Aristeia Advisors, L.L.C. (collectively, “Aristeia”) may be deemed the beneficial owners of the securities described herein in their capacity as the investment manager, trading manager, and/or general partner, as the case may be, of Aristeia Master, L.P., ASIG International Limited, |
DS Liquid Div RVA ARST, LLC, and Windermere Ireland Fund PLC (each a “Fund” and collectively, the “Funds”), which are the holders of such securities, as shown below. As investment manager, trading advisor and/or general partner of each Fund, Aristeia has voting and investment control with respect to the securities held by each Fund. Anthony M. Frascella and William R. Techar are the co-Chief Investment Officers of Aristeia. Each of Aristeia and such individuals disclaims beneficial ownership of the securities referenced herein except to the extent of its or his direct or indirect economic interest in the Funds. |
(4) | These securities are being registered for resale in accordance with the terms of the Registration Rights Agreement, as described under “ Certain Relationships and Related Party Transactions—Registration Rights Agreement |
(5) | Consists of (a) 1,405,484 shares of Common Stock and (b) options to purchase 3,077,023 shares of Common Stock that are exercisable within 60 days of August 16, 2021. Blaire LaCorte is our Chief Executive Officer and a member of our Board. |
(6) | Blackstone Alternative Solutions L.L.C. is the investment manager of Blackstone Aqua Master Sub-Fund, a sub-fund of Blackstone Global Master Fund ICAV (the “Aqua Fund”). Blackstone Holdings I L.P. is the sole member of Blackstone Alternative Solutions L.L.C. Blackstone Holdings I/II GP L.L.C. is the general partner of Blackstone Holdings I L.P. Blackstone Holdings II L.P. is the sole member of Blackstone Strategic Opportunity Associates L.L.C. Blackstone Holdings I/II GP L.L.C. is the general partner of Blackstone Holdings II L.P. Blackstone Inc. is the sole member of Blackstone Holdings I/II GP L.L.C. Blackstone Group Management L.L.C. is the sole holder of the Series II preferred stock of Blackstone Inc. Blackstone Group Management L.L.C. is wholly owned by its senior managing directors and controlled by its founder, Stephen A. Schwarzman. Each of such Blackstone entities and Mr. Schwarzman may be deemed to beneficially own the securities beneficially owned by the Aqua Fund directly or indirectly controlled by it or him, but each (other than Aqua Fund to the extent of its direct holdings) disclaims beneficial ownership of such securities. The principal business address of each of the entities listed in this footnote is c/o Blackstone Inc., 345 Park Avenue, New York, New York 10154. |
(7) | Nantahala Capital Management, LLC is a Registered Investment Adviser and has been delegated the legal power to vote and/or direct the disposition of such securities on behalf of the Selling Securityholder as a General Partner or Investment Manager and would be considered the beneficial owner of such securities. The above shall not be deemed to be an admission by the record owners or the Selling Securityholder that they are themselves beneficial owners of these securities for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or any other purpose. Wilmot Harkey and Daniel Mack are managing members of Nantahala Capital Management, LLC and may be deemed to have voting and dispositive power over the securities held by the Selling Securityholder. |
(8) | Castle Hook Partners LP, the investment manager of Castle Hook Master Fund Ltd., has voting and investment power over the securities held by Castle Hook Master Fund Ltd. David Rogers is the Chief Investment Officer, Founding Partner and Managing Member of Castle Hook Partners LP. Castle Hook Master Fund Ltd. and David Rogers each disclaims beneficial ownership of these securities. The address of Castle Hook Master Fund Ltd. is 250 West 55th Street, 32nd Floor, New York, New York 10019. |
(9) | Consists of (i) 3,426,000 Founder Shares, (ii) 500,000 shares of Common Stock acquired in the Private Placement, (iii) 500,000 PIPE shares, and (iv) 166,666 Warrants (and 166,666 shares of Common Stock issuable upon exercise of such Warrants). Cantor Fitzgerald, L.P. (“Cantor”) is the sole member of CF Finance Holdings III. CF Group Management, Inc. (“CFGM”) is the managing general partner of Cantor. Howard W. Lutnick is the Chairman and Chief Executive Officer of CFGM and also the trustee of CFGM’s sole stockholder. As such, each of Cantor, CFGM and Mr. Lutnick may be deemed to have beneficial ownership of the securities directly held by CF Finance Holdings III. Each such entity or person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly. The business address for the entities and individual discussed in this footnote is 110 East 59th Street, New York NY 10022. |
(10) | As of August 16, 2021, includes (1) 500,000 PIPE Shares and (ii) 75,814 additional shares of Class A Common Stock. Citadel Advisors LLC (“Citadel Advisors”) is the portfolio manager of Citadel Multi-Strategy Equities Master Fund Ltd. (“Citadel”). Citadel Advisors Holdings LP (“CAH”) is the sole member of Citadel Advisors. Citadel GP LLC (“CGP”) is the general partner of CAH. Kenneth Griffin owns a |
controlling interest in CGP. Mr. Griffin, as the owner of a controlling interest in CGP, may be deemed to have shared power to vote and/or shared power to dispose of the securities held by Citadel. The foregoing shall not be construed as an admission that Mr. Griffin or any of the Citadel related entities is the beneficial owner of any of our securities other than the securities actually owned by such person (if any). The business address of Citadel is c/o Citadel Advisors LLC 601 Lexington Ave., New York, New York 10022. |
(11) | Voting and investment power over the shares held by Context Partners Master Fund, L.P. resides with Context Capital Management, LLC. The address of Context Partners Master Fund, L.P. is 7724 Girard Avenue, Third Floor, La Jolla, CA 92037. |
(12) | Cooper Road, LLC is an entity controlled by Jay Bloom. |
(13) | Cooper Road Acquisition LLC is an entity controlled by Jordan Bloom. |
(14) | Greg Van Guilder, the Chief Investment Officer of ECMC Group, Inc. and James V. McKeon, Julia Gouw, Derek Langhauser, James Runcie, K. Paul Singh, Jennifer Anderson, Diana Ingram, Jack O’Connell, Maurice M. Salter and Jeremy Wheaton, members of the board of directors of ECMC Group, Inc., may be deemed to beneficially own the shares of common stock held by ECMC Group, Inc. Each of these individuals disclaims beneficial ownership of such shares. The address of ECMC Group, Inc. is 111 Washington Avenue South, Suite 1400 Minneapolis, MN 55401. |
(15) | General Motors Ventures LLC (“GM Ventures”) currently holds more than 5% of our Capital Stock. GM Ventures is a wholly owned subsidiary of General Motors Holdings LLC (“GM Holdings”). GM Holdings is a wholly owned subsidiary of General Motors Company (“GM”). The principal office of each of GM Ventures, GM Holdings, and GM is 300 Renaissance Center, Detroit, MI, 48265. |
(16) | Grandwin Enterprises Limited (“GW”) is wholly owned by Pak To Leung. As such, Pak To Leung may be deemed to share voting and investment power with respect to the shares held by GW. The registered address for GW is Morgan & Morgan Building, Pasea Estate, Road Town, Tortola, British Virgin Islands. |
(17) | Millennium Management LLC (“Millennium Management”) is the general partner of the managing member of Integrated Core Strategies (US) LLC (“Integrated Core Strategies”). Millennium Group Management LLC (“Millennium Group Management”) is the managing member of Millennium Management. The managing member of Millennium Group Management is a trust of which Israel A. Englander, a United States citizen (“Mr. Englander”), currently serves as the sole voting trustee. Accordingly, Millennium Management, Millennium Group Management and Mr. Englander may be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies. An entity under common control with Integrated Core Strategies, Millennium Management, and Millennium Group Management beneficially owned 83,333 additional shares of common stock issuable upon exercise of Warrants. The foregoing should not be construed as an admission by Millennium Management, Millennium Group Management or Mr. Englander as to beneficial ownership of the referenced securities. The address of Integrated Core Strategies is c/o Millennium Management, 99 Park Avenue, New York, New York 10022. |
(18) | Kepos Capital LP is the investment manager of the selling securityholder and Kepos Partners LLC is the General Partner of the selling securityholder and each may be deemed to have voting and dispositive power with respect to the shares. The general partner of Kepos Capital LP is Kepos Capital GP LLC (the “Kepos GP”) and the Managing Member of Kepos Partners LLC is Kepos Partners MM LLC (“Kepos MM”). Mark Carhart controls Kepos GP and Kepos MM and, accordingly, may be deemed to have voting and dispositive power with respect to the shares held by this selling securityholder. Mr. Carhart disclaims beneficial ownership of the shares held by the selling securityholder. The address of the foregoing individuals and entities is c/o Kepos Capital LP, 11 Times Square, 35 th Flr, New York, NY 10036. |
(19) | Consists of (a) 13,405,167 shares of our common stock held by Kleiner Perkins Caufield & Byers XVI, LLC(“KPCB XVI”), 458,898 shares held by KPCB XVI Founders Fund, LLC (“XVI Founders”), 2,362,303 shares held by Kleiner Perkins Caufield & Byers XIX, LLC (“KPCB XIX”), 22,179 shares held by Kleiner Perkins XIX Friends, LLC (“XIX Friends”) and 52,150 shares held by KPCB XIX Founders Fund, LLC (“XIX Founders”). All shares are held for convenience in the name of “KPCB Holdings, Inc., as nominee” for the accounts of such individuals and entities. The managing member of KPCB XVI and XVI Founders is KPCB XVI Associates, LLC (“KPCB XVI Associates”). L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI and XVI Founders. Such managing |
members disclaim beneficial ownership of all shares held by KPCB XVI and XVI Founders except to the extent of their pecuniary interest therein. The managing member of KPCB XIX, XIX Friends and XIX Founders is KPCB XIX Associates, LLC (“KPCB XIX Associates”). Ilya Fushman, Mamoon Hamid and Wen Hsieh, the managing members of KPCB XIX Associates, exercise shared voting and dispositive control over the shares held by KPCB XIX, XIX Friends and XIX Founders. Such managing members disclaim beneficial ownership of all shares held by KPCB XIX, XIX Friends and XIX Founders except to the extent of their pecuniary interest therein. The principal business address for all entities and individuals affiliated with Kleiner Perkins Caufield & Byers is c/o Kleiner Perkins Caufield & Byers, LLC, 2750 Sand Hill Road, Menlo Park, CA 94025. KPCB Holdings, Inc., as nominee is affiliated with current members of our Board and currently holds more than 5% of our Capital Stock. |
(20) | Reflects shares held for the account of Linden Capital L.P . (“ th Floor, New York, New York 10022. |
(21) | Consists of (a) 18,316,664 shares of Common Stock and (b) options to purchase 7,441 shares of Common Stock that are exercisable within 60 days of August 16, 2021. Luis Dussan is our Chief Technology Officer and Chief Product Strategist and a member of our Board. |
(22) | Luxor Capital Group, LP is the investment manager of Lugard Road Capital Master Fund, LP. Jonathan Green, in his position as Portfolio Manager at Luxor Capital Group, LP, may be deemed to have voting and investment power with respect to the securities owned by Lugard Road Capital Master Fund, LP. Mr. Green disclaims beneficial ownership of any such securities. The mailing address of Lugard Road Capital Master Fund, LP is 1114 Avenue of the Americas, 28th Fl New York, NY 10036. |
(23) | Luxor Capital Group, LP is the investment manager of Luxor Capital Partners Offshore Master Fund, LP. Christian Leone, in his position as Portfolio Manager at Luxor Capital Group, LP, may be deemed to have voting and investment power with respect to the securities owned by Luxor Capital Partners Offshore Master Fund, LP. Mr. Leone disclaims beneficial ownership of any such securities. The mailing address of Luxor Capital Partners Offshore Master Fund, LP is 1114 Avenue of the Americas, 28th Fl New York, NY 10036. |
(24) | Luxor Capital Group, LP is the investment manager of Luxor Capital Partners, LP. Christian Leone, in his position as Portfolio Manager at Luxor Capital Group, LP, may be deemed to have voting and investment power with respect to the securities owned by Luxor Capital Partners, LP. Mr. Leone disclaims beneficial ownership of any such securities. The mailing address of Luxor Capital Partners, LP is 1114 Avenue of the Americas, 28th Fl New York, NY 10036. |
(25) | Luxor Capital Group, LP is the investment manager of Luxor Wavefront, LP. Christian Leone, in his position as Portfolio Manager at Luxor Capital Group, LP, may be deemed to have voting and investment power with respect to the securities owned by Luxor Wavefront, LP. Mr. Leone disclaims beneficial ownership of any such securities. The mailing address of Luxor Wavefront, LP is 1114 Avenue of the Americas, 28th Fl New York, NY 10036. |
(26) | Securities held by MMCAP International Inc. SPC. Matthew MacIsaac is the Secretary of MM Asset Management Inc., which is the investment advisor to MMCAP International Inc. SPC, and may be deemed to having voting and dispositive control over the securities held by the Selling Securityholder. |
(27) | Moore Capital Management, LP, the investment manager of MMF LT, LLC, has voting and investment control of the shares held by MMF LT, LLC. Mr. Louis M. Bacon controls the general partner of Moore Capital Management, LP and may be deemed the beneficial owner of the shares of the Company held by MMF LT, LLC. Mr. Bacon also is the indirect majority owner of MMF LT, LLC. The address of MMF LT, LLC, Moore Capital Management, LP and Mr. Bacon is 11 Times Square, New York, New York 10036. |
(28) | Norwich Assets Limited is wholly owned by Mr. Chung Cho Yee, Mico. As such, he may be deemed to share voting and investment power with respect to the shares held. The business address of the reporting person is 31/F, Bank of America Tower, Central, Hong Kong. |
(29) | A majority of Patriot Capital Limited (“Patriot”) isbeneficially owned by Mr. Silas Kei Fong Chou. As such, Mr. Silas Kei Fong Chou may be deemed to share voting and investment power with respect to the shares held by Patriot. The business address of the reporting person is12/F, Novel Industrial Building, 850-870 Lai Chi Kok Road, Cheung Sha Wan, Kowloon, Hong Kong. |
(30) | Consists of options to purchase 821,884 shares of Common Stock exercisable within 60 days of August 16, 2021. Robert Brown is out Treasurer, Chief Financial Officer and Chief Accounting Officer. |
(31) | Dispositive and voting power over the shares held by Spring Creek Capital, LLC is held by its president, Eric Butcher. The business address for Spring Creek Capital, LLC is 4111 E 37th Street N, Wichita, Kansas 67220. |
(32) | Stonehaven Ventures Limited (“SV”) is wholly and beneficially owned by Mr. Silas Kei Fong CHOU. As such, Mr. Silas Kei Fong CHOU may be deemed to share voting and investment power with respect to the shares held by SV. The business address of the reporting person is 12/F, Novel Industrial Building, 850-870 Lai Chi Kok Road, Cheung Sha Wan, Kowloon, Hong Kong. |
(33) | Hudson Bay Capital Management LP, the investment manager of Tech Opportunities LLC, has voting and investment power over these securities. Sander Gerber is the managing member of Hudson Bay Capital GP LLC, which is the general partner of Hudson Bay Capital Management LP. Each of Tech Opportunities LLC and Sander Gerber disclaims beneficial ownership over these securities. The business address of the entities and persons named herein is c/o Hudson Bay Capital Management LP 28 Havemeyer Place, 2nd Floor Greenwich CT 06830. |
(34) | Includes 842,355 shares of common stock held directly by TPG Public Equity Partners Master Fund, L.P., 583,175 shares of common stock held directly by TPG Public Equity Partners Long Opportunities Master Fund, L.P., and 74,470 shares of common stock held directly by TPG Public Equity Partners, LP (together with TPG Public Equity Partners Master Fund, L.P. and TPG Public Equity Partners Long Opportunities Master Fund, L.P. the “TPEP Funds”). The general partner of each of the TPEP Funds is TPG PEP GenPar Governance, L.P., whose general partner is TPG PEP GenPar Advisors, L.P., whose general partner is TPG Holdings III, L.P., whose general partner is TPG Holdings III-A, L.P., whose general partner is TPG Holdings III-A, Inc., whose sole shareholder is TPG Group Holdings (SBS), L.P., whose general partner is TPG Group Holdings (SBS) Advisors, LLC, whose sole member is TPG Group Holdings (SBS) Advisors, Inc. David Bonderman and James G. Coulter are sole shareholders of TPG Group Holdings (SBS) Advisors, Inc. and may therefore be deemed to beneficially own the shares of common stock held by the TPG Funds. Messrs. Bonderman and Coulter disclaim beneficial ownership of the shares of common stock held by the TPG Funds except to the extent of their pecuniary interest therein, if any. |
• | purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus; |
• | ordinary brokerage transactions and transactions in which the broker solicits purchasers; |
• | block trades in which the broker-dealer so engaged will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction; |
• | an over-the-counter distribution in accordance with the rules of the Nasdaq; |
• | through trading plans entered into by a Selling Securityholder pursuant to Rule 10b5-1 under the Exchange Act, that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their securities on the basis of parameters described in such trading plans; |
• | to or through underwriters or broker-dealers; |
• | settlement of short sales entered into after the date of this prospectus; |
• | agreements with broker-dealers to sell a specified number of securities at a stipulated price per share and/or warrant; |
• | in “at the market” offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange or sales made through a market maker other than on an ex-change or other similar offerings through sales agents; |
• | in privately negotiated transactions, whether through an options exchange or otherwise; |
• | in options transactions; |
• | through a combination of any of the above methods of sale; or |
• | any other method permitted pursuant to applicable law. |
AEye, Inc. Financial Statements |
||||
Unaudited Condensed Consolidated Financial Statements as of and for the periods ended June 30, 2021 and 2020 |
||||
F-2 | ||||
F-3 | ||||
F-4 | ||||
F-5 | ||||
F-6 | ||||
Audited Consolidated Financial Statements as of and for the periods ended December 31, 2020 and 2019 |
||||
F-24 | ||||
F-25 | ||||
F-26 | ||||
F-27 | ||||
F-28 | ||||
F-29 | ||||
CF Finance Acquisition Corp. III Financial Statements |
||||
Unaudited Financial Statements of CF Finance Acquisition Corp. III |
||||
F-56 | ||||
F-57 | ||||
F-58 | ||||
F-59 | ||||
F-60 | ||||
Audited Financial Statements of CF Finance Acquisition Corp. III |
||||
F-79 | ||||
F-80 | ||||
F-81 | ||||
F-82 | ||||
F-83 | ||||
F-84 |
June 30, 2021 |
December 31, 2020 |
|||||||
(Unaudited) |
||||||||
ASSETS |
||||||||
CURRENT ASSETS: |
||||||||
Cash and cash equivalents |
$ | 11,226 | $ | 15,275 | ||||
Accounts receivable, net |
138 | 156 | ||||||
Inventories, net |
4,468 | 2,655 | ||||||
Prepaid and other current assets |
1,711 | 1,396 | ||||||
|
|
|
|
|||||
Total current assets |
17,543 | 19,482 | ||||||
Property and equipment—Net |
4,697 | 4,865 | ||||||
Restricted cash |
2,150 | 1,222 | ||||||
Other noncurrent assets |
3,890 | 316 | ||||||
|
|
|
|
|||||
Total assets |
$ | 28,280 | $ | 25,885 | ||||
|
|
|
|
|||||
LIABILITIES AND STOCKHOLDERS’ DEFICIT |
||||||||
CURRENT LIABILITIES: |
||||||||
Accounts payable |
4,782 | 1,807 | ||||||
Accrued expenses and other current liabilities |
6,048 | 3,356 | ||||||
Deferred revenue (including $200 from related parties) |
272 | 660 | ||||||
Convertible notes |
37,759 | 29,079 | ||||||
Borrowing - net of issuance costs, current portion |
11,334 | 2,693 | ||||||
|
|
|
|
|||||
Total current liabilities |
60,195 | 37,595 | ||||||
Deferred rent, noncurrent |
3,333 | 3,631 | ||||||
Borrowings - net of issuance costs, noncurrent |
1,242 | 2,884 | ||||||
|
|
|
|
|||||
Total liabilities |
$ | 64,770 | $ | 44,110 | ||||
|
|
|
|
|||||
COMMITMENTS AND CONTINGENCIES (Note 15) |
||||||||
STOCKHOLDERS’ DEFICIT: |
||||||||
Preferred stock—$0.00001 par value: 17,500,000 shares authorized at June 30, 2021 and December 31, 2020 ; 16,383,725 shares issued and outstanding at June 30, 2021 and December 31, 2020 ; aggregate liquidation preference of $63,162 at June 30, 2021 and December 31, 2020 |
62,639 | 62,639 | ||||||
Common stock—$0.00001 par value: 37,500,000 shares authorized at June 30, 2021 and December 31, 2020 ; 10,886,441 and 10,838,010 shares issued and outstanding at June 30, 2021 and December 31, 2020 |
— | — | ||||||
Additional paid-in capital |
10,239 | 5,920 | ||||||
Accumulated deficit |
(109,368 | ) | (86,784 | ) | ||||
Total stockholders’ deficit |
(36,490 | ) | (18,225 | ) | ||||
|
|
|
|
|||||
Total liabilities and stockholders’ deficit |
$ | 28,280 | $ | 25,885 | ||||
|
|
|
|
Three months ended June 30, |
Six months ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
REVENUE: |
||||||||||||||||
Prototype sales (including $141 and $161 thousand from related parties for the three and six months ended June 30, 2021, respectively) |
$ | 228 | $ | — | $ | 461 | $ | 63 | ||||||||
Development contracts (including $500 thousand from related parties for the three and six months ended June 30, 2021) |
519 | — | 615 | 100 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenues |
747 | — | 1,076 | 163 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Cost of revenue |
454 | 36 | 1,071 | 147 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross (loss) profit |
293 | (36 | ) | 5 | 16 | |||||||||||
OPERATING EXPENSES: |
||||||||||||||||
Research and development |
5,726 | 3,423 | 11,562 | 7,960 | ||||||||||||
Sales and marketing |
1,911 | 640 | 3,498 | 1,938 | ||||||||||||
General and administrative |
4,750 | 1,505 | 7,760 | 3,212 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating expenses |
12,387 | 5,568 | 22,820 | 13,110 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
LOSS FROM OPERATIONS |
(12,094 | ) | (5,604 | ) | (22,815 | ) | (13,094 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
OTHER INCOME (EXPENSE): |
||||||||||||||||
Change in fair value of embedded derivative liability and warrant liability |
(16 | ) | (1,519 | ) | (119 | ) | (82 | ) | ||||||||
Gain on PPP loan forgiveness |
2,297 | — | 2,297 | — | ||||||||||||
Interest income |
2 | 2 | 5 | 13 | ||||||||||||
Interest expense |
(1,264 | ) | (381 | ) | (1,952 | ) | (554 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other income (expense), net |
1,019 | (1,898 | ) | 231 | (623 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Provision for income tax expense |
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
NET LOSS AND COMPREHENSIVE LOSS |
$ | (11,075 | ) | $ | (7,502 | ) | $ | (22,584 | ) | $ | (13,717 | ) | ||||
|
|
|
|
|
|
|
|
|||||||||
PER SHARE DATA |
||||||||||||||||
Net loss per common share (basic and diluted) |
(1.02 | ) | (0.66 | ) | (2.08 | ) | (1.21 | ) | ||||||||
Weighted average common shares outstanding (basic and diluted) |
10,884,301 | 11,316,842 | 10,868,166 | 11,304,295 |
Preferred Stock | Common Stock | Additional Paid in Capital |
Accumulated Deficit |
Total | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount (1) | |||||||||||||||||||||||||
BALANCE—December 31, 2019 |
16,383,725 | $ | 62,639 | 11,283,838 | $ | — | $ | 3,305 | $ | (60,233 | ) | $ | 5,711 | |||||||||||||||
Issuance of common stock upon exercise of stock options |
21,770 | 14 | 14 | |||||||||||||||||||||||||
Convertible notes |
10,211 | 10,211 | ||||||||||||||||||||||||||
Stock-based compensation |
280 | 280 | ||||||||||||||||||||||||||
Net loss |
(6,215 | ) | (6,215 | ) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
BALANCE—March 31, 2020 |
16,383,725 | $ | 62,639 | 11,305,608 | $ | — | $ | 13,810 | $ | (66,448 | ) | $ | 10,001 | |||||||||||||||
Issuance of common stock upon exercise of stock options |
58,555 | 68 | 68 | |||||||||||||||||||||||||
Stock-based compensation |
263 | 263 | ||||||||||||||||||||||||||
Convertible notes |
(10,211 | ) | (10,211 | ) | ||||||||||||||||||||||||
Net loss |
(7,502 | ) | (7,502 | ) | ||||||||||||||||||||||||
BALANCE—June 30, 2020 |
16,383,725 | $ | 62,639 | 11,364,163 | $ | — | $ | 3,930 | $ | (73,950 | ) | $ | (7,381 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
BALANCE—December 31, 2020 |
16,383,725 | $ | 62,639 | 10,838,010 | — | $ | 5,920 | $ | (86,784 | ) | $ | (18,225 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Issuance of common stock upon exercise of stock options |
46,152 | — | 85 | 85 | ||||||||||||||||||||||||
Stock-based compensation |
1,610 | 1,610 | ||||||||||||||||||||||||||
Net loss |
(11,509 | ) | (11,509 | ) | ||||||||||||||||||||||||
BALANCE—March 31, 2021 |
16,383,725 | $ | 62,639 | 10,884,162 | $ | — | $ | 7,615 | $ | (98,293 | ) | $ | (28,039 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Issuance of common stock upon exercise of stock options |
2,279 | — | 4 | 4 | ||||||||||||||||||||||||
Stock-based compensation |
— | — | 2,620 | — | 2,620 | |||||||||||||||||||||||
Net loss |
(11,075 | ) | (11,075 | ) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
BALANCE—June 30, 2021 |
16,383,725 | $ | 62,639 | 10,886,441 | $ | — | $ | 10,239 | $ | (109,368 | ) | $ | (36,490 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, |
||||||||
2021 |
2020 |
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
||||||||
Net loss |
$ | (22,584 | ) | $ | (13,717 | ) | ||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
||||||||
Depreciation and amortization |
498 | 420 | ||||||
Change in fair value of embedded derivative liability and warrant liability |
119 | 82 | ||||||
Noncash gain on PPP loan forgiveness |
(2,297 | ) | — | |||||
Stock-based compensation |
4,230 | 543 | ||||||
Amortization of issuance costs |
437 | 32 | ||||||
Amortization of debt issuance costs |
543 | 282 | ||||||
Other |
189 | (23 | ) | |||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
18 | (484 | ) | |||||
Inventories, net |
(1,813 | ) | (754 | ) | ||||
Prepaids and other current assets |
(316 | ) | 3,013 | |||||
Other noncurrent assets |
(144 | ) | 104 | |||||
Accounts payable |
1,513 | (150 | ) | |||||
Accrued expenses and other current liabilities |
1,953 | 185 | ||||||
Deferred rent, noncurrent |
(297 | ) | (242 | ) | ||||
Deferred revenue |
(388 | ) | 704 | |||||
|
|
|
|
|||||
Net cash provided by (used in) operating activities |
$ | (18,339 | ) | $ | (10,005 | ) | ||
|
|
|
|
|||||
CASH FLOWS FROM INVESTING ACTIVITIES: |
||||||||
Purchase of property and equipment |
(245 | ) | (3,914 | ) | ||||
|
|
|
|
|||||
Net cash provided by (used in) investing activities |
$ | (245 | ) | $ | (3,914 | ) | ||
|
|
|
|
|||||
CASH FLOWS FROM FINANCING ACTIVITIES: |
||||||||
Proceeds from the exercise of stock options |
$ | 89 | $ | 82 | ||||
Proceeds from the issuance of convertible notes |
8,045 | 10,376 | ||||||
Proceeds from SVB financing facility |
10,000 | 2,270 | ||||||
Principal payments for SVB credit facility |
(667 | ) | (445 | ) | ||||
Payments of deferred financing costs |
(1,287 | ) | — | |||||
Payment of debt issuance costs |
(717 | ) | (54 | ) | ||||
|
|
|
|
|||||
Net cash provided by (used in) financing activities |
$ | 15,463 | $ | 12,229 | ||||
|
|
|
|
|||||
NET (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH |
(3,121 | ) | (1,690 | ) | ||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—Beginning of period |
16,497 | 8,205 | ||||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—Ending |
$ | 13,376 | $ | 6,515 | ||||
SUPPLEMENTAL CASH FLOW INFORMATION: |
||||||||
Cash paid for interest |
142 | 98 | ||||||
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES: |
||||||||
Property and equipment additions included in accounts payable and accrued liabilities |
85 | — | ||||||
Deferred financings costs included in accounts payable and accrued liabilities |
2,143 | — | ||||||
Noncash gain on extinguishment of debt related to PPP loan |
2,297 | — |
1. |
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
2. |
FAIR VALUE MEASUREMENTS |
As of June 30, 2021 |
||||||||||||||||
(unaudited) |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Liabilities |
||||||||||||||||
Warrant liability |
$ | — | $ | — | $ | 229 | $ | 229 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total financial liabilities |
$ | — | $ | — | $ | 229 | $ | 229 | ||||||||
|
|
|
|
|
|
|
|
December 31, 2020 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Liabilities |
||||||||||||||||
Warrant liability |
$ | — | $ | — | $ | 93 | $ | 93 | ||||||||
Embedded derivative liability |
$ | — | $ | — | $ | 17 | $ | 17 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total financial liabilities |
$ | — | $ | — | $ | 110 | $ | 110 | ||||||||
|
|
|
|
|
|
|
|
Embedded Derivative Liability |
Warrant Liability |
Total |
||||||||||
Balance at December 31, 2020 |
$ | 17 | $ | 93 | $ | 110 | ||||||
(Gain) loss in fair value included in other income (expense) |
(17 | ) | 136 | 119 | ||||||||
|
|
|
|
|
|
|||||||
Balance at June 30, 2021 (unaudited) |
$ | — | $ | 229 | $ | 229 | ||||||
|
|
|
|
|
|
3. |
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH |
June 30, 2021 |
December 31, 2020 |
|||||||
(unaudited) |
||||||||
Cash and cash equivalents |
$ | 11,226 | $ | 15,275 | ||||
Restricted cash |
2,150 | 1,222 | ||||||
|
|
|
|
|||||
Total cash, cash equivalents, and restricted cash |
$ | 13,376 | $ | 16,497 | ||||
|
|
|
|
4. |
INVENTORIES |
June 30, 2021 |
December 31, 2020 |
|||||||
(unaudited) |
||||||||
Raw materials |
$ | 1,662 | $ | 1,123 | ||||
Work in-process |
2,499 | 1,337 | ||||||
Finished goods |
307 | 195 | ||||||
|
|
|
|
|||||
Total inventory, net |
$ | 4,468 | $ | 2,655 | ||||
|
|
|
|
5. |
OTHER NONCURRENT ASSETS |
June 30, 2021 |
December 31, 2020 |
|||||||
(unaudited) |
||||||||
Deferred financing costs |
$ | 3,719 | $ | 289 | ||||
Other noncurrent assets |
171 | 27 | ||||||
|
|
|
|
|||||
Total other noncurrent assets |
$ | 3,890 | $ | 316 | ||||
|
|
|
|
6. |
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES |
June 30, 2021 |
December 31, 2020 |
|||||||
(unaudited) |
||||||||
Payroll liabilities |
$ | 1,673 | $ | 1,014 | ||||
Accrued interest |
938 | 391 | ||||||
Accrued purchases and other |
2,862 | 1,406 | ||||||
Deferred rent - current portion |
575 | 545 | ||||||
|
|
|
|
|||||
Accrued expenses and other current liabilities |
$ | 6,048 | $ | 3,356 | ||||
|
|
|
|
7. |
PROPERTY AND EQUIPMENT, NET |
June 30, 2021 |
December 31, 2020 |
|||||||
(unaudited) |
||||||||
Lab and testing equipment |
$ | 751 | $ | 625 | ||||
Computers and related equipment |
328 | 218 | ||||||
Office furniture and equipment |
338 | 338 | ||||||
Vehicles |
205 | 165 | ||||||
Leasehold improvements |
4,709 | 4,709 | ||||||
Construction in progress |
54 | — | ||||||
|
|
|
|
|||||
Total property and equipment |
6,385 | 6,055 | ||||||
Less accumulated depreciation and amortization |
(1,688 | ) | (1,190 | ) | ||||
|
|
|
|
|||||
Property and equipment—net |
$ | 4,697 | $ | 4,865 | ||||
|
|
|
|
8. |
BORROWINGS |
June 30, 2021 |
December 31, 2020 |
|||||||
(unaudited) |
||||||||
Silicon Valley Bank financing facility |
$ | 10,000 | — | |||||
Silicon Valley Bank credit facility |
2,666 | $ | 3,334 | |||||
Payroll Protection Program (PPP) Loan |
— | 2,270 | ||||||
Unamortized debt issuance costs - SVB financing and credit facility |
(90 | ) | (27 | ) | ||||
|
|
|
|
|||||
Total borrowings, net of issuance costs |
$ | 12,567 | $ | 5,577 | ||||
|
|
|
|
|||||
Borrowings - net of issuance costs, current portion |
$ | 11,334 | $ | 2,693 | ||||
Borrowings - net of issuance costs, noncurrent portion |
1,242 | 2,884 | ||||||
|
|
|
|
|||||
Total borrowings, net issuance costs |
$ | 12,567 | $ | 5,577 | ||||
|
|
|
|
9. |
CONVERTIBLE NOTES |
(i) | the original issue price per share paid in the Next Financing Stock multiplied by 90%; and |
(ii) | the price obtained by dividing $250,000 by the number of outstanding shares of common stock of the Company immediately prior to the Next Financing, as applicable. |
June 30, 2021 |
December 31, 2020 |
|||||||
(unaudited) |
||||||||
Convertible notes - face value |
$ | 38,035 | $ | 29,990 | ||||
Unamortized issuance costs |
(67 | ) | (175 | ) | ||||
Unamortized debt discount |
(209 | ) | (753 | ) | ||||
Embedded derivative liability |
— | 17 | ||||||
|
|
|
|
|||||
Convertible notes - current |
$ | 37,759 | $ | 29,079 | ||||
|
|
|
|
• | Beginning Stock Price. The Company’s equity value was estimated based on a third party appraisal, which was understood to reasonably represent the value at the Valuation Date. |
• | Term. The time until a financing is raised was estimated by management. |
• | Volatility. Since the Company’s stock is not publicly traded, the expected volatilities are based on the historical and implied volatilities of similar companies whose stock prices are publicly available, after considering the industry, stage of life cycle, size, market capitalization, and financial leverage of the other companies. |
• | Risk-free Rate. The risk-free rate is consistent with the estimated term until a future funding round. |
June 30, 2021 (unaudited) |
||||
Time until Event/SPAC (years) |
0.13 | |||
Volatility of the underlying asset |
65.00 | % | ||
Risk-free rate of interest |
10.40 | % |
10. |
INTEREST EXPENSE |
Three months ended June 30, |
Six months ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
(unaudited) |
||||||||||||||||
Interest on term loan debt |
$ | 269 | $ | 67 | $ | 395 | $ | 130 | ||||||||
Interest on PPP loan |
5 | 4 | 11 | 4 | ||||||||||||
Interest on convertible note |
288 | 78 | 566 | 106 | ||||||||||||
Amortization of issuance costs |
426 | 15 | 437 | 32 | ||||||||||||
Amortization of debt discount |
276 | 217 | 543 | 282 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Interest expense |
$ | 1,264 | $ | 381 | $ | 1,952 | $ | 554 | ||||||||
|
|
|
|
|
|
|
|
11. |
STOCKHOLDERS’ DEFICIT |
Shared Authorized |
Shares Outstanding |
Liquidation Preference |
Carrying Amount |
|||||||||||||
Series A |
9,234,087 | 9,226,734 | $ | 18,844 | $ | 18,595 | ||||||||||
Series B |
8,265,913 | 7,156,991 | 44,318 | 44,044 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
17,500,000 | 16,383,725 | $ | 63,162 | $ | 62,639 | ||||||||||
|
|
|
|
|
|
|
|
June 30, 2021 |
December 31, 2020 |
|||||||
(unaudited) |
||||||||
Shares reserved for preferred stock outstanding |
16,383,725 | 16,383,725 | ||||||
Shares reserved for Series A preferred stock warrant |
7,353 | 7,353 | ||||||
Shares reserved for warrant to purchase common stock |
61,612 | 61,612 | ||||||
Options issued and outstanding |
8,379,760 | 8,497,693 | ||||||
Shares available for future option grants |
386,150 | 6,648 | ||||||
|
|
|
|
|||||
Total |
25,218,600 | 24,957,031 | ||||||
|
|
|
|
12. |
STOCK-BASED COMPENSATION |
Outstanding Stock Options |
Weighted Average Exercise Price |
Weighted Average Contractual Life (Years) |
Aggregate Intrinsic Value |
|||||||||||||
Balance at December 31, 2020 |
8,497,693 | $ | 1.79 | 8.3 | $ | 112,548 | ||||||||||
Granted |
— | — | ||||||||||||||
Exercised |
(49,265 | ) | 1.80 | |||||||||||||
Forfeited |
(345,306 | ) | 1.97 | |||||||||||||
Expired |
(46,060 | ) | 1.18 | |||||||||||||
|
|
|||||||||||||||
Balance at June 30, 2021 (unaudited) |
8,057,062 | $ | 1.78 | 7.9 | $ | 255,464 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Vested and expected to vest as of June 30, 2021 (unaudited) |
8,057,062 | $ | 1.73 | 7.6 | $ | 234,165 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Vested and exercisable as of June 30, 2021 (unaudited) |
4,296,916 | $ | 1.36 | 6.6 | $ | 138,058 | ||||||||||
|
|
|
|
|
|
|
|
Common Stock |
Weighted Average Grant date fair value |
|||||||
Unvested at December 31, 2020 |
— | — | ||||||
|
|
|
|
|||||
Granted |
467,697 | $ | 32.51 | |||||
Vested |
(33,615 | ) | $ | 32.60 | ||||
|
|
|
|
|||||
Unvested at June 30, 2021 (unaudited) |
434,082 | $ | 32.50 | |||||
|
|
|
|
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
(unaudited) |
||||||||||||||||
Research and development |
$ | 776 | $ | 111 | $ | 1,397 | $ | 247 | ||||||||
Sales and marketing |
415 | 38 | 773 | 81 | ||||||||||||
General and administrative |
1429 | 114 | 2,060 | 215 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total stock-based compensation expense |
$ | 2,620 | $ | 263 | $ | 4,230 | $ | 543 | ||||||||
|
|
|
|
|
|
|
|
13. |
REVENUE |
Three months ended June 30, |
Six months ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
(unaudited) |
||||||||||||||||
Revenue by primary geographical market: |
||||||||||||||||
United States |
$ | 154 | $ | — | $ | 387 | $ | 128 | ||||||||
Germany |
500 | — | 500 | — | ||||||||||||
Other European countries |
64 | — | 64 | 35 | ||||||||||||
Asia |
29 | — | 125 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 747 | $ | — | $ | 1,076 | $ | 163 | ||||||||
Revenue by timing of recognition: |
||||||||||||||||
Recognized at a point in time |
$ | 720 | $ | — | $ | 1,033 | $ | 163 | ||||||||
Recognized over time |
27 | — | 43 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 747 | $ | — | $ | 1,076 | $ | 163 | ||||||||
|
|
|
|
|
|
|
|
As of June 30, 2021 |
||||
(unaudited) |
||||
Contract liabilities, current |
$ | 272 | ||
Contract liabilities, long-term |
— | |||
|
|
|||
Total |
$ | 272 | ||
|
|
Beginning balance - April 1, 2021 |
$ | 779 | ||
Revenue recognized that was included in the contract liabilities beginning balance |
(527 | ) | ||
Increase due to cash received and performance obligations not yet satisfied during the period |
20 | |||
|
|
|||
Ending balance - June 30, 2021 (unaudited) |
$ | 272 | ||
|
|
14. |
INCOME TAXES |
15. |
COMMITMENTS AND CONTINGENCIES |
Operating Leases |
||||
(unaudited) |
||||
Six months ended 2021 |
$ | 1,143 | ||
Years ended: |
||||
2022 |
2,331 | |||
2023 |
2,342 | |||
2024 |
2,412 | |||
2025 and after |
4,824 | |||
|
|
|||
Total minimum lease payments |
$ | 13,052 | ||
|
|
16. |
RELATED PARTIES |
17. |
NET LOSS PER SHARE |
Three months ended June 30, |
Six months ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
(unaudited) |
||||||||||||||||
Numerator: |
||||||||||||||||
Net loss attributable to common shareholders |
$ | (11,075 | ) | $ | (7,502 | ) | $ | (22,584 | ) | $ | (13,717 | ) | ||||
Denominator: |
||||||||||||||||
Weighted average common shares outstanding- Basic |
10,884,301 | 11,316,842 | 10,868,166 | 11,304,295 | ||||||||||||
Dilutive effect of potential common shares |
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average common shares outstanding- Diluted |
10,884,301 | 11,316,842 | 10,868,166 | 11,304,295 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss per common share (basic and diluted) |
$ | (1.02 | ) | $ | (0.66 | ) | $ | (2.08 | ) | $ | (1.21 | ) | ||||
|
|
|
|
|
|
|
|
June 30, 2021 |
June 30, 2020 |
|||||||
(unaudited) |
||||||||
Warrants to purchase common stock |
61,612 | 61,612 | ||||||
Warrants to purchase Series A preferred stock warrant |
7,353 | 7,353 | ||||||
Options to purchase common stock |
8,379,760 | 5,387,133 | ||||||
Conversion of Series A preferred stock |
9,226,734 | 9,226,734 | ||||||
Conversion of Series B preferred stock |
7,156,991 | 7,156,991 | ||||||
Conversion of convertible notes |
5,886,180 | 1,502,385 | ||||||
|
|
|
|
|||||
Total |
30,718,630 | 23,342,208 | ||||||
|
|
|
|
18. |
SUBSEQUENT EVENTS |
2020 |
2019 |
|||||||
ASSETS |
||||||||
CURRENT ASSETS: |
||||||||
Cash and cash equivalents |
$ | 15,275 | $ | 5,855 | ||||
Accounts receivable, net (including $22 from related parties) |
156 | 143 | ||||||
Inventories, net |
2,655 | 2,418 | ||||||
Prepaid and other current assets |
1,396 | 5,207 | ||||||
Total current assets |
19,482 | 13,623 | ||||||
Property and equipment, net |
4,865 | 4,965 | ||||||
Other noncurrent assets |
1,538 | 2,472 | ||||||
|
|
|
|
|||||
Total assets |
$ | 25,885 | $ | 21,060 | ||||
|
|
|
|
|||||
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) |
||||||||
CURRENT LIABILITIES: |
||||||||
Accounts payable |
1,807 | 4,469 | ||||||
Accrued expenses and other current liabilities |
3,356 | 2,019 | ||||||
Deferred revenue (including $565 from related parties) |
660 | 950 | ||||||
Convertible notes |
29,079 | — | ||||||
Borrowings – net of issuance costs, current portion |
2,693 | 1,333 | ||||||
Total current liabilities |
37,595 | 8,771 | ||||||
Deferred rent, noncurrent |
3,631 | 4,127 | ||||||
Borrowings – net of issuance costs, noncurrent |
2,884 | 2,451 | ||||||
|
|
|
|
|||||
Total liabilities |
$ | 44,110 | $ | 15,349 | ||||
|
|
|
|
|||||
COMMITMENTS AND CONTINGENCIES (Note 16) |
||||||||
STOCKHOLDERS’ (DEFICIT) EQUITY: |
||||||||
Preferred stock – $0.00001 par value: 17,500,000 shares authorized at December 31, 2020 and 2019; 16,383,725 shares issued and outstanding at December 31, 2020 and 2019; aggregate liquidation preference of $63,162 at December 31, 2020 and 2019 |
62,639 | 62,639 | ||||||
Common stock – $0.00001 par value: 37,500,000 shares authorized at December 31, 2020 and 2019; 10,838,010 and 11,283,838 shares issued and outstanding at December 31, 2020 and 2019 |
— | — | ||||||
Additional paid-in capital |
5,920 | 3,305 | ||||||
Accumulated deficit |
(86,784 | ) | (60,233 | ) | ||||
Total stockholders’ (deficit) equity |
(18,225 | ) | 5,711 | |||||
|
|
|
|
|||||
Total liabilities and stockholders’ (deficit) equity |
$ | 25,885 | $ | 21,060 | ||||
|
|
|
|
2020 |
2019 |
|||||||
REVENUE: |
||||||||
Prototype sales (including $60 from related parties) |
$ | 365 | $ | 291 | ||||
Development contracts (including $1,150 from related parties) |
1,214 | 1,175 | ||||||
|
|
|
|
|||||
Total revenues |
1,579 | 1,466 | ||||||
|
|
|
|
|||||
Cost of revenue |
808 | 253 | ||||||
|
|
|
|
|||||
Gross profit |
771 | 1,213 | ||||||
OPERATING EXPENSES: |
||||||||
Research and development |
17,130 | 18,661 | ||||||
Sales and marketing |
3,408 | 4,244 | ||||||
General and administrative |
6,715 | 7,129 | ||||||
|
|
|
|
|||||
Total operating expenses |
27,253 | 30,034 | ||||||
|
|
|
|
|||||
LOSS FROM OPERATIONS |
(26,482 | ) | (28,821 | ) | ||||
|
|
|
|
|||||
OTHER INCOME (EXPENSE): |
||||||||
Change in fair value of embedded derivatives and warrants |
1,410 | — | ||||||
Interest income |
23 | 266 | ||||||
Interest expense |
(1,502 | ) | (96 | ) | ||||
|
|
|
|
|||||
Total other income (expense), net |
(69 | ) | 170 | |||||
|
|
|
|
|||||
Provision for income tax expense |
— | — | ||||||
|
|
|
|
|||||
NET LOSS AND COMPREHENSIVE LOSS |
$ | (26,551 | ) | $ | (28,651 | ) | ||
|
|
|
|
|||||
PER SHARE DATA |
||||||||
Net loss per share (basic and diluted) |
(2.36 | ) | (2.58 | ) | ||||
Weighted average shares outstanding (basic and diluted) |
11,247,251 | 11,099,850 |
Preferred Stock |
Common Stock |
Additional Paid in Capital |
Accumulated Deficit |
Total |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount (1) |
|||||||||||||||||||||||||
BALANCE – January 1, 2019 |
15,899,254 | $ | 59,669 | 10,965,329 | $ | — | $ | 2,257 | $ | (31,582 | ) | $ | 30,344 | |||||||||||||||
Issuance of common stock upon exercise of stock options |
318,509 | — | 196 | 196 | ||||||||||||||||||||||||
Issuance of common stock warrant |
86 | 86 | ||||||||||||||||||||||||||
Issuance of Series B preferred stock, net of issuance costs of $30 |
484,471 | 2,970 | 2,970 | |||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | 766 | — | 766 | |||||||||||||||||||||
Net loss |
(28,651 | ) | (28,651 | ) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
BALANCE – December 31, 2019 |
16,383,725 | $ | 62,639 | 11,283,838 | $ | — | $ | 3,305 | $ | (60,233 | ) | $ | 5,711 | |||||||||||||||
Issuance of common stock upon exercise of stock options |
504,524 | — | 663 | 663 | ||||||||||||||||||||||||
Repurchase of common stock |
(950,352 | ) | — | — | — | |||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | 1,952 | — | 1,952 | |||||||||||||||||||||
Net loss |
(26,551 | ) | (26,551 | ) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
BALANCE – December 31, 2020 |
16,383,725 | $ | 62,639 | 10,838,010 | $ | — | $ | 5,920 | $ | (86,784 | ) | $ | (18,225 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Amounts within common stock round to zero |
2020 |
2019 |
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
||||||||
Net loss |
$ | (26,551 | ) | $ | (28,651 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Depreciation and amortization |
922 | 343 | ||||||
Noncash interest expense related to bank loans |
97 | 18 | ||||||
Change in fair value of embedded derivatives and warrants |
(1,410 | ) | — | |||||
Stock-based compensation |
1,952 | 766 | ||||||
Amortization of debt issuance costs |
830 | — | ||||||
Other |
68 | (64 | ) | |||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
(13 | ) | 249 | |||||
Inventories, net |
(237 | ) | (1,332 | ) | ||||
Prepaids and other current assets |
3,811 | (4,210 | ) | |||||
Other noncurrent assets |
(193 | ) | (10 | ) | ||||
Accounts payable |
484 | 939 | ||||||
Accrued expenses and other current liabilities |
1,377 | 1,102 | ||||||
Deferred revenue |
(290 | ) | 950 | |||||
Deferred rents, noncurrent |
(496 | ) | 4,071 | |||||
|
|
|
|
|||||
Net cash used in operating activities |
$ | (19,689 | ) | $ | (25,829 | ) | ||
|
|
|
|
|||||
CASH FLOWS FROM INVESTING ACTIVITIES: |
||||||||
Purchase of property and equipment |
$ | (4,036 | ) | $ | (1,178 | ) | ||
Maturity of short-term investment |
— | 6,000 | ||||||
|
|
|
|
|||||
Net cash (used in) provided by investing activities |
$ | (4,036 | ) | $ | 4,822 | |||
CASH FLOWS FROM FINANCING ACTIVITIES: |
||||||||
Proceeds from the exercise of stock options |
$ | 663 | $ | 196 | ||||
Proceeds from the issuance of Series B preferred stock – net of issuance costs of $30 |
— | 2,970 | ||||||
Proceeds from the issuance of convertible notes |
29,990 | — | ||||||
Proceeds from bank loans |
2,270 | 4,000 | ||||||
Principal payments on bank loan |
(667 | ) | (1,939 | ) | ||||
Payment of debt issuance costs |
(238 | ) | (135 | ) | ||||
|
|
|
|
|||||
Net cash provided by financing activities |
$ | 32,018 | $ | 5,092 | ||||
|
|
|
|
|||||
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH |
8,293 | (15,915 | ) | |||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH – Beginning of year |
8,205 | 24,120 | ||||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH – End of year |
$ | 16,498 | $ | 8,205 | ||||
SUPPLEMENTAL CASH FLOW INFORMATION: |
||||||||
Cash paid for interest |
197 | 76 | ||||||
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES: |
||||||||
Property and equipment additions paid with lease incentive |
— | 56 | ||||||
Property and equipment additions included in accounts payable and accrued liabilities |
13 | 3,159 | ||||||
Issuance of common stock warrant in connection with credit facility |
— | 86 |
• | Identification of the contract, or contracts, with a customer |
• | Identification of the performance obligations in the contract |
• | Determination of the transaction price |
• | Allocation of the transaction price to the performance obligations in the contract |
• | Recognition of revenue when, or as, the Company satisfies a performance obligation |
December 31, 2020 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Liabilities |
||||||||||||||||
Warrant liability |
$ | — | $ | — | $ | 93 | $ | 93 | ||||||||
Embedded derivative liabilities |
$ | — | $ | — | $ | 17 | $ | 17 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total financial liabilities |
$ | — | $ | — | $ | 110 | $ | 110 | ||||||||
|
|
|
|
|
|
|
|
Embedded Derivative |
Warrants |
Total |
||||||||||
Balance at December 31, 2019 |
$ | — | $ | — | $ | — | ||||||
Initial fair value of embedded derivative |
1,520 | — | 1,520 | |||||||||
(Gain)/loss in fair value included in other income (expense) |
(1,503 | ) | 93 | (1,410 | ) | |||||||
|
|
|
|
|
|
|||||||
Balance at December 31, 2020 |
$ | 17 | $ | 93 | $ | 110 | ||||||
|
|
|
|
|
|
2020 |
2019 |
|||||||
Cash and cash equivalents |
$ | 15,275 | $ | 5,855 | ||||
Restricted cash |
1,223 | 2,350 | ||||||
|
|
|
|
|||||
Total cash, cash equivalents, and restricted cash |
$ | 16,498 | $ | 8,205 | ||||
|
|
|
|
2020 |
2019 |
|||||||
Raw materials |
$ | 1,123 | $ | 1,269 | ||||
Work in-process |
1,337 | 1,027 | ||||||
Finished goods |
195 | 122 | ||||||
|
|
|
|
|||||
Total inventory, net |
$ | 2,655 | $ | 2,418 | ||||
|
|
|
|
2020 |
2019 |
|||||||
Receivables for tenant improvements |
$ | 453 | $ | 3,845 | ||||
Taxes receivable |
43 | 500 | ||||||
Advances to suppliers & employees |
351 | 5 | ||||||
Prepaid rent |
200 | 214 | ||||||
Prepaid software licenses |
178 | 253 | ||||||
Prepaid insurance, taxes, lease costs, and other |
171 | 390 | ||||||
|
|
|
|
|||||
Total prepaid and other current assets |
$ | 1,396 | $ | 5,207 | ||||
|
|
|
|
2020 |
2019 |
|||||||
Trade receivables |
$ | 134 | $ | 143 | ||||
Trade receivables – related parties |
22 | — | ||||||
|
|
|
|
|||||
Total accounts receivables |
$ | 156 | $ | 143 | ||||
|
|
|
|
2020 |
2019 |
|||||||
Payroll liabilities |
$ | 1,014 | $ | 933 | ||||
Sales tax payable |
82 | 30 | ||||||
Accrued interest |
391 | 12 | ||||||
Accrued purchases and other |
1,324 | 488 | ||||||
Deferred rent – current portion |
545 | 556 | ||||||
|
|
|
|
|||||
Accrued expenses and other current liabilities |
$ | 3,356 | $ | 2,019 | ||||
|
|
|
|
2020 |
2019 |
|||||||
Lab and testing equipment |
$ | 625 | $ | 637 | ||||
Computers and related equipment |
218 | 337 | ||||||
Office furniture and equipment |
338 | 195 | ||||||
Vehicles |
165 | 165 | ||||||
Leasehold improvements |
4,709 | 269 | ||||||
Construction in progress |
— | 4,051 | ||||||
|
|
|
|
|||||
Total property and equipment |
6,055 | 5,654 | ||||||
Less accumulated depreciation and amortization |
(1,190 | ) | (689 | ) | ||||
|
|
|
|
|||||
Property and equipment – net |
$ | 4,865 | $ | 4,965 | ||||
|
|
|
|
2020 |
2019 |
|||||||
Silicon Valley Bank term loan |
$ | 3,333 | $ | 4,000 | ||||
Silicon Valley Bank PPP Loan |
2,270 | — | ||||||
Unamortized debt discount |
(26 | ) | (216 | ) | ||||
Current maturities |
(2,693 | ) | (1,333 | ) | ||||
|
|
|
|
|||||
Borrowings, net of current maturities |
$ | 2,884 | $ | 2,451 | ||||
|
|
|
|
Year |
Amount |
|||
2021 |
$ | 2,693 | ||
2022 |
2,244 | |||
2023 |
667 | |||
|
|
|||
$ | 5,604 | |||
|
|
December 31, 2020 |
||||
Stock price |
$ | 15.03 | ||
Expected term (years) |
5.8 | |||
Expected volatility |
45.6 | % | ||
Risk-free interest |
0.4 | % | ||
Dividend yield |
— | % |
(i) | the original issue price per share paid in the Next Financing Stock multiplied by 90%; and |
(ii) | the price obtained by dividing $250,000 by the number of outstanding shares of common stock of the Company immediately prior to the Next Financing, as applicable. |
2020 |
||||
Convertible notes – face value |
$ | 29,990 | ||
Unamortized fees |
(175 | ) | ||
Debt discount |
(753 | ) | ||
Derivative liability |
17 | |||
|
|
|||
Convertible notes – current |
$ | 29,079 | ||
|
|
• | Beginning Stock Price. The Company’s equity value was estimated based on a third party appraisal, which was understood to reasonably represent the value at the Valuation Date. |
• | Term. The time until a financing is raised was estimated by management. |
• | Volatility. Since the Company’s stock is not publicly traded, the expected volatilities are based on the historical and implied volatilities of similar companies whose stock prices are publicly available, after considering the industry, stage of life cycle, size, market capitalization, and financial leverage of the other companies. |
• | Risk-free Rate. The risk-free rate is consistent with the estimated term until a future funding round. |
December 31, 2020 |
||||
SPAC event scenario (years) |
0.41 | |||
Financing event scenario (years) |
0.25 | |||
Maturity (years) |
0.65 | |||
Volatility of the underlying asset |
77.50 | % | ||
Risk-free rate of interest |
0.09 | % |
2020 |
2019 |
|||||||
Interest on term loan debt |
$ | 200 | $ | 78 | ||||
Interest on PPP Loan |
16 | — | ||||||
Interest on convertible note |
359 | — | ||||||
Debt discount amortization |
927 | 18 | ||||||
|
|
|
|
|||||
Interest expense |
1,502 | 96 | ||||||
|
|
|
|
Shared Authorized |
Shares Outstanding |
Liquidation Preference |
Carrying Amount |
|||||||||||||
Series A |
9,234,087 | 9,226,734 | $ | 18,844 | $ | 18,595 | ||||||||||
Series B |
8,265,913 | 7,156,991 | 44,318 | 44,044 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
17,500,000 | 16,383,725 | $ | 63,162 | $ | 62,639 | ||||||||||
|
|
|
|
|
|
|
|
2020 |
2019 |
|||||||
Shares reserved for preferred stock outstanding |
16,383,725 | 16,383,725 | ||||||
Shares reserved for Series A preferred stock warrant |
7,353 | 7,353 | ||||||
Shares reserved for warrant to purchase shares of common stock |
61,612 | 68,458 | ||||||
Options issued and outstanding |
8,497,693 | 5,800,426 | ||||||
Shares available for future option grants |
6,648 | 958,087 | ||||||
|
|
|
|
|||||
Total |
24,957,031 | 23,218,049 | ||||||
|
|
|
|
Outstanding Stock Options |
Weighted Average Exercise Price |
Weighted Average Contractual Life (Years) |
Aggregate Intrinsic Value (in thousands) |
|||||||||||||
Balance at December 31, 2018 |
3,585,704 | $ | 0.56 | 8.1 | $ | 6,325 | ||||||||||
Granted |
2,829,917 | 2.32 | ||||||||||||||
Exercised |
(318,509 | ) | 0.62 | |||||||||||||
Forfeited |
(253,729 | ) | 1.23 | |||||||||||||
Expired |
(42,957 | ) | 0.66 | |||||||||||||
|
|
|
|
|||||||||||||
Balance at December 31, 2019 |
5,800,426 | 1.38 | 8.3 | 5,446 | ||||||||||||
Granted |
4,411,431 | 2.33 | ||||||||||||||
Exercised |
(504,524 | ) | 1.31 | |||||||||||||
Forfeited |
(1,014,010 | ) | 2.04 | |||||||||||||
Expired |
(195,630 | ) | 1.98 | |||||||||||||
Balance at December 31, 2020 |
8,497,693 | 1.79 | 8.3 | 112,548 | ||||||||||||
|
|
|
|
|||||||||||||
Vested and expected to vest as of December 31, 2020 |
8,497,693 | 1.79 | 8.3 | 112,548 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Vested and exercisable as of December 31, 2020 |
3,546,022 | $ | 1.21 | 7.0 | $ | 49,022 | ||||||||||
|
|
|
|
|
|
|
|
2020 |
2019 |
|||||||
Research and development |
$ | 702 | $ | 376 | ||||
Sales and marketing |
249 | 144 | ||||||
General and administrative |
1,001 | 246 | ||||||
|
|
|
|
|||||
Total stock-based compensation expense |
$ | 1,952 | $ | 766 | ||||
|
|
|
|
2020 |
2019 |
|||||||
Unrecognized stock-based compensation expense |
$ | 11,562 | $ | 2,275 | ||||
|
|
|
|
|||||
Weighted average recognition period |
2.9 | 2.9 | ||||||
|
|
|
|
2020 |
2019 |
|||||||
Expected term (in years) |
5.8 | 6.0 | ||||||
Risk-free interest rate |
0.4 | % | 2.1 | % | ||||
Expected volatility |
45.6 | % | 40.9 | % | ||||
Expected dividend yield |
— | % | — | % |
2020 |
2019 |
|||||||
Revenue by primary geographical market: |
||||||||
United States |
$ | 330 | $ | 385 | ||||
Europe |
135 | 1,025 | ||||||
Asia |
1,114 | 56 | ||||||
|
|
|
|
|||||
Total |
$ | 1,579 | $ | 1,466 | ||||
|
|
|
|
|||||
Revenue by timing of recognition: |
||||||||
Recognized at a point in time |
$ | 1,515 | $ | 466 | ||||
Recognized over time |
64 | 1,000 | ||||||
|
|
|
|
|||||
Total |
$ | 1,579 | $ | 1,466 | ||||
|
|
|
|
As of December 31, 2020 |
||||
Contract liabilities, Current |
$ | 660 | ||
|
|
|||
Total |
$ | 660 | ||
|
|
2020 |
2019 |
|||||||
Beginning balance |
$ | 950 | $ | — | ||||
Revenue recognized that was included in the contract liabilities beginning balance |
(450 | ) | — | |||||
Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period |
160 | 950 | ||||||
|
|
|
|
|||||
Ending balance |
$ | 660 | $ | 950 | ||||
|
|
|
|
2020 |
2019 |
|||||||
U.S. federal tax benefit at statutory rate |
21.0 | % | 21.0 | % | ||||
State income taxes, net of federal benefit |
3.5 | % | 3.1 | % | ||||
Non-deductible expenses and other |
0.3 | % | (0.2 | )% | ||||
Share-based compensation |
(1.5 | )% | (0.5 | )% | ||||
Research and development credits |
2.5 | % | 1.1 | % | ||||
Foreign rate differential |
(4.3 | )% | (2.9 | )% | ||||
Change in valuation allowance, net |
(21.5 | )% | (21.6 | )% | ||||
|
|
|
|
|||||
Effective tax rate |
— | % | — | % | ||||
|
|
|
|
2020 |
2019 |
|||||||
Deferred tax assets: |
||||||||
Net operating loss carryforwards |
$ | 17,011 | $ | 12,276 | ||||
Research and development credit carryforward |
2,810 | 1,826 | ||||||
Stock-based compensation |
51 | 42 | ||||||
Property and equipment |
40 | |||||||
Other accruals |
464 | 545 | ||||||
|
|
|
|
|||||
Gross deferred tax assets |
20,376 | 14,688 | ||||||
Valuation allowance |
(20,376 | ) | (14,677 | ) | ||||
|
|
|
|
|||||
Net deferred tax assets |
— | 11 | ||||||
Deferred tax liabilities: |
||||||||
Property and equipment |
— | (11 | ) | |||||
|
|
|
|
|||||
Total deferred tax assets (liabilities) – net |
$ | — | $ | — | ||||
|
|
|
|
2020 |
2019 |
|||||||
Unrecognized tax benefits as of the beginning of the year |
$ | 938 | $ | 647 | ||||
Increases related to prior year tax provisions |
(14 | ) | — | |||||
Increase related to current year tax provisions |
286 | 291 | ||||||
|
|
|
|
|||||
Unrecognized tax benefits as of the end of the year |
$ | 1,210 | $ | 938 | ||||
|
|
|
|
Years Ending December 31 |
Operating Leases |
|||
2021 |
$ | 2,286 | ||
2022 |
2,330 | |||
2023 |
2,342 | |||
2024 |
2,412 | |||
2025 and after |
4,824 | |||
|
|
|||
Total minimum lease payments |
$ |
14,194 |
||
|
|
2020 |
2019 |
|||||||
Numerator: |
||||||||
Net loss attributable to common shareholders (in thousands) |
$ | (26,551 | ) | $ | (28,651 | ) | ||
Denominator: |
||||||||
Weighted average Common shares outstanding- Basic |
11,247,251 | 11,099,850 | ||||||
Dilutive effect of potential common shares |
— | — | ||||||
|
|
|
|
|||||
Weighted average Common shares outstanding- Diluted |
11,247,251 | 11,099,850 | ||||||
|
|
|
|
|||||
Net loss per share attributable to Common shareholders – Basic and Diluted |
$ | (2.36 | ) | $ | (2.58 | ) | ||
|
|
|
|
2020 |
2019 |
|||||||
Warrants to purchase common stock |
61,612 | 68,458 | ||||||
Warrants to purchase preferred stock |
7,353 | 7,353 | ||||||
Options to purchase common stock |
8,497,693 | 5,800,426 | ||||||
Conversion of Series A Preferred stock |
9,226,734 | 9,226,734 | ||||||
Conversion of Series B Preferred stock |
7,156,991 | 7,156,991 | ||||||
Conversion of convertible notes |
4,385,497 | — | ||||||
|
|
|
|
|||||
Total |
29,335,880 | 22,259,962 | ||||||
|
|
|
|
June 30, 2021 |
December 31, 2020 |
|||||||
(Unaudited) |
||||||||
Assets: |
||||||||
Current Assets: |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
Other assets |
||||||||
Cash equivalents held in Trust Account |
||||||||
|
|
|
|
|||||
Total Assets |
$ |
$ |
||||||
|
|
|
|
|||||
Liabilities and Stockholders’ Equity: |
||||||||
Current Liabilities: |
||||||||
Accrued expenses |
$ | $ | ||||||
Payables to related party |
||||||||
Sponsor loan – promissory notes |
||||||||
Franchise tax payable |
||||||||
Income tax payable |
||||||||
|
|
|
|
|||||
Total Current Liabilities |
||||||||
Warrant liability |
||||||||
|
|
|
|
|||||
Total Liabilities |
||||||||
|
|
|
|
|||||
Commitments and Contingencies (Note 5) |
||||||||
Class A common stock, |
||||||||
Stockholders’ Equity: |
||||||||
Preferred stock, $ |
||||||||
Class A common stock, $ |
||||||||
Class B common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total Stockholders’ Equity |
||||||||
|
|
|
|
|||||
Total Liabilities and Stockholders’ Equity |
$ |
$ |
||||||
|
|
|
|
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
General and administrative costs |
$ | $ | — | $ | $ | — | ||||||||||
Administrative expenses – related party |
— | — | ||||||||||||||
Franchise tax expense |
— | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss from operations |
( |
) | — | ( |
) | — | ||||||||||
Interest income on investments held in Trust Account |
— | — | ||||||||||||||
Changes in fair value of warrant liability |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss |
$ | ( |
) | $ | — | $ | ( |
) | $ | — | ||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average number of shares of common stock outstanding: |
||||||||||||||||
Class A – Public shares |
— | — | ||||||||||||||
Class A – Private placement |
— | — | ||||||||||||||
Class B – Common stock |
(1) |
(1) | ||||||||||||||
Basic and diluted net income (loss) per share: |
||||||||||||||||
Class A – Public shares |
$ | $ | — | $ | $ | — | ||||||||||
Class A – Private placement |
$ | ( |
) | $ | — | $ | ( |
) | $ | — | ||||||
Class B – Common stock |
$ | ( |
) | $ | $ | ( |
) | $ |
(1) | Excludes an aggregate of up to 750,000 shares subject to forfeiture if the over-allotment option is not exercised in full by the underwriter. This number has been retroactively restated to reflect the recapitalization of the Company in the form of a 2.5-for-1 |
Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Total Stockholders’ Equity |
|||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance – December 31, 2020 |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||||||||||
Shares subject to possible redemption |
( |
) | ( |
) | — | — | ( |
) | — | ( |
) | |||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – March 31, 2021 |
( |
) | ||||||||||||||||||||||||||
Shares subject to possible redemption |
— | — | — | |||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – June 30, 2021 |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Total Stockholders’ Equity |
|||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance – December 31, 2019 |
$ | (1) |
$ | $ | $ | ( |
) | $ | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net income |
— | — | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – March 31, 2020 |
( |
) | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net income |
— | — | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – June 30, 2020 |
$ | (1) |
$ | $ | $ | ( |
) | $ | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | This number has been retroactively restated to reflect the recapitalization of the Company in the form of a 2.5-for-1 |
For the Six Months Ended June 30, |
||||||||
2021 |
2020 |
|||||||
Cash flows from operating activities: |
||||||||
Net loss |
$ | ( |
) | $ | ||||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
General and administrative expenses paid by related party |
||||||||
Interest income on investments held in Trust Account |
( |
) | ||||||
Changes in fair value of warrant liability |
||||||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses and other assets |
||||||||
Accrued expenses |
||||||||
Income tax payable |
||||||||
Payable to related party |
||||||||
Franchise tax payable |
||||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) | ||||||
|
|
|
|
|||||
Cash flows from investing activities: |
||||||||
Proceeds from Trust Account to pay tax |
||||||||
Cash deposited to Trust Account |
( |
) | ||||||
|
|
|
|
|||||
Net cash used by investing activities |
( |
) | ||||||
|
|
|
|
|||||
Cash flows from financing activities: |
||||||||
Proceeds from related party – Sponsor loan |
||||||||
Payment of related party payable |
( |
) | ||||||
|
|
|
|
|||||
Net cash provided by financing activities |
||||||||
|
|
|
|
|||||
Net change in cash |
||||||||
Cash – beginning of the period |
||||||||
|
|
|
|
|||||
Cash – end of the period |
$ | $ | ||||||
|
|
|
|
|||||
Supplemental disclosure of noncash financing activities: |
||||||||
Prepaid expenses paid with payables to related party |
$ | $ | ||||||
|
|
|
|
|||||
Changes in Class A common stock subject to possible redemption |
$ | ( |
) | $ | ||||
|
|
|
|
For the Three Months Ended June 30, |
||||||||
2021 |
2020 |
|||||||
Redeemable shares of Class A common stock |
||||||||
Numerator: earnings allocable to redeemable shares of Class A common stock |
||||||||
Interest income on investments held in Trust Account |
$ | $ | ||||||
|
|
|
|
|||||
Less franchise tax available to be withdrawn from the Trust Account |
$ | ( |
) | $ | ||||
Net earnings |
$ | $ | ||||||
Denominator: weighted average number of redeemable shares of Class A common stock |
||||||||
Basic and diluted net loss per redeemable share of Class A common stock |
$ | $ | ||||||
Non-redeemable shares of Class A private placement common stock and Class B common stock |
||||||||
Numerator: net loss minus redeemable net earnings |
||||||||
Loss from operations |
$ | ( |
) | $ | ||||
Less franchise tax available to be withdrawn from the Trust Account |
$ | $ | ||||||
Change in fair value of warrant liability attributable to non-redeemable shares of Class A private placement common stock and Class B common stock |
$ | ( |
) | $ | ||||
|
|
|
|
|||||
Non-redeemable net loss |
$ | ( |
) | $ | ||||
Denominator: weighted average number of non-redeemable shares of Class A private placement common stock and Class B common stock |
||||||||
Non-redeemable shares of Class A private placement common stock and Class B common stock, basic and diluted |
||||||||
Basic and diluted net loss per non-redeemable share of Class A private placement common stock and share of Class B common stock |
$ | ( |
) | $ |
For the Six Months Ended June 30, |
||||||||
2021 |
2020 |
|||||||
Redeemable shares of Class A common stock |
||||||||
Numerator: earnings allocable to redeemable shares of Class A common stock |
||||||||
Interest income on investments held in Trust Account |
$ | $ | ||||||
|
|
|
|
|||||
Less franchise tax available to be withdrawn from the Trust Account |
$ | ( |
) | $ | ||||
Net earnings |
$ | $ | ||||||
Denominator: weighted average number of redeemable shares of Class A common stock |
||||||||
Basic and diluted net loss per redeemable share of Class A common stock |
$ | $ | ||||||
Non-redeemable shares of Class A private placement common stock and Class B common stock |
||||||||
Numerator: net loss minus redeemable net earnings |
||||||||
Loss from operations |
$ | ( |
) | $ | ||||
Less franchise tax available to be withdrawn from the Trust Account |
$ | |||||||
Change in fair value of warrant liability attributable to non-redeemable shares of Class A private placement common stock and Class B common stock |
$ | ( |
) | $ | ||||
|
|
|
|
|||||
Non-redeemable net loss |
$ | ( |
) | $ | ||||
Denominator: weighted average number of non-redeemable shares of Class A private placement common stock and Class B common stock |
||||||||
Non-redeemable shares of Class A private placement common stock and Class B common stock, basic and diluted |
||||||||
Basic and diluted net loss per non-redeemable share of Class A private placement common stock and Class B common stock |
$ | ( |
) | $ |
• | in whole and not in part; |
• | at a price of $ |
• | at any time during the exercise period; |
• | upon a minimum of 30 days’ prior written notice of redemption; |
• | if, and only if, the last reported sale price of the Company’s common stock equals or exceeds $ 20-trading days within a 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders; and |
• | if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants. |
• | Level 1 measurements — unadjusted observable inputs such as quoted prices for identical instruments in active markets; |
• | Level 2 measurements — inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3 measurements — unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
Description |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
Total |
||||||||||||
Assets: |
||||||||||||||||
Assets held in Trust Account — U.S. Treasury Securities |
$ | $ | $ | |
$ | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities: |
||||||||||||||||
Warrant liability |
$ | $ | $ | |
$ | |||||||||||
|
|
|
|
|
|
|
|
Description |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
Total |
||||||||||||
Assets: |
||||||||||||||||
Assets held in Trust Account — U.S. Treasury Securities |
$ | $ | |
$ | $ | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities: |
||||||||||||||||
Warrant liability |
$ | $ | |
$ | $ | |||||||||||
|
|
|
|
|
|
|
|
December 31, 2020 |
||||
Risk-free interest rate |
% | |||
Expected term (years) |
||||
Expected volatility |
% | |||
Exercise price |
$ | |||
Stock price |
$ | |||
Dividend yield |
% |
Private Placement |
Public |
Warrant Liability |
||||||||||
Fair value as of December 31, 2020 |
$ | $ | $ | |||||||||
Change in valuation inputs or other assumptions (1) |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Fair Value as at March 31, 2021 |
||||||||||||
Change in valuation inputs or other assumptions (1) |
||||||||||||
|
|
|
|
|
|
|||||||
Fair value as of June 30, 2021 (2) |
$ | $ | $ | |||||||||
|
|
|
|
|
|
(1) | Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liability in the statement of operations. |
(2) | Due to the use of quoted prices in an active market (Level 1) and the use of observable inputs for similar assets or liabilities (Level 2) for Public Warrants and Private Placement Warrants, respectively, subsequent to initial measurement, the Company had transfers out of Level 3 totaling $ |
December 31, |
||||||||
2020 |
2019 |
|||||||
(restated) |
||||||||
Assets: |
||||||||
Current assets: |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
— | |||||||
|
|
|
|
|||||
Total current assets |
||||||||
Other assets |
— | |||||||
Cash equivalents held in Trust Account |
— | |||||||
|
|
|
|
|||||
Total Assets |
$ |
$ |
||||||
|
|
|
|
|||||
Liabilities and Stockholders’ Equity: |
||||||||
Current liabilities: |
||||||||
Accrued expenses |
$ | $ | ||||||
Payables to related party |
||||||||
Sponsor loan – promissory notes |
— | |||||||
Franchise tax payable |
— | |||||||
Income tax payable |
— | |||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
Warrant liability |
— | |||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
|||||
Commitments and Contingencies |
||||||||
Class A common stock, |
— | |||||||
Stockholders’ Equity: |
||||||||
Preferred stock, $ |
||||||||
Class A common stock, $ |
— | |||||||
Class B common stock, $ |
(1) | |||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total Stockholders’ Equity |
||||||||
|
|
|
|
|||||
Total Liabilities and Stockholders’ Equity |
$ |
$ |
||||||
|
|
|
|
(1) | This number has been retroactively restated to reflect the recapitalization of the Company in the form of a 2.5-for-1 stock split and subsequent return to the Company, which resulted in cancellation of 8,625,000 Founder Shares (see Note 6). |
For the Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
(restated) |
||||||||
General and administrative costs |
$ | $ | ||||||
Administrative expenses – related party |
— | |||||||
Franchise tax expense |
||||||||
|
|
|
|
|||||
Loss from operations |
( |
) | ( |
) | ||||
Interest income on investments held in Trust Account |
— | |||||||
|
|
|
|
|||||
Change in fair value of warrant liability |
( |
) | — | |||||
|
|
|
|
|||||
Loss before income tax expense |
( |
) | ( |
) | ||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
|||||
Weighted average number of common shares outstanding: |
||||||||
Class A – Public shares |
— | |||||||
Class A – Private placement |
— | |||||||
Class B – Common stock |
(1) | |||||||
Basic and diluted net income (loss) per share: |
||||||||
Class A – Public shares |
$ | $ | — | |||||
Class A – Private placement |
$ | ( |
) | $ | — | |||
Class B – Common stock |
$ | ( |
) | $ | ( |
) |
(1) | Excludes an aggregate of up to 750,000 shares subject to forfeiture if the over-allotment option is not exercised in full by the underwriter. This number has been retroactively restated to reflect the recapitalization of the Company in the form of a 2.5-for-1 stock split and subsequent return to the Company, which resulted in cancellation of 8,625,000 Founder Shares (see Note 6). |
For the years ended December 31, 2020 (restated) and 2019 |
||||||||||||||||||||||||||||
Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Total Stockholders’ Equity |
|||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance – December 31, 2018 |
$ | (1) |
$ | $ | $ | ( |
) | $ | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net loss |
— | — | ( |
) | ( |
) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – December 31, 2019 |
$ | (1) |
$ | $ | $ | ( |
) | $ | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Sale of Class A common stock in initial public offering |
— | — | — | |||||||||||||||||||||||||
Sale of private placement Class A common stock to Sponsor in private placement |
— | — | — | |||||||||||||||||||||||||
Offering costs |
— | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||
Class A common stock subject to possible redemption |
( |
) | ( |
) | — | — | ( |
) | — | ( |
) | |||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – December 31, 2020 |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | This number has been retroactively restated to reflect the recapitalization of the Company in the form of a 2.5-for-1 stock split and subsequent return to the Company, which resulted in cancellation of 8,625,000 Founder Shares (see Note 6). |
For the Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
(restated) |
||||||||
Cash Flows from Operating Activities: |
||||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Adjustments to reconcile net loss to net cash provided by operating activities: |
||||||||
General and administrative expenses paid by related party |
||||||||
Interest income on investments held in Trust Account |
( |
) | — | |||||
Change in fair value of warrant liability |
— | |||||||
Changes in operating assets and liabilities: |
||||||||
Accrued expenses |
( |
) | ||||||
Franchise tax payable |
— | |||||||
Income tax payable |
— | |||||||
|
|
|
|
|||||
Net cash provided by operating activities |
— | — | ||||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Cash deposited in Trust Account |
( |
) | — | |||||
|
|
|
|
|||||
Net cash used in investing activities |
( |
) | — | |||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from note payable to related party |
— | |||||||
Deferred offering costs paid by related party |
— | |||||||
Repayment of note payable to related party |
( |
) | — | |||||
Proceeds from collection of stock subscription receivable from stockholder |
— | |||||||
Proceeds received from initial public offering |
— | |||||||
Proceeds received from private placement |
— | |||||||
Offering costs paid |
( |
) | — | |||||
|
|
|
|
|||||
Net cash provided by financing activities |
||||||||
|
|
|
|
|||||
Net change in cash |
( |
) | ||||||
Cash – beginning of the period |
— | |||||||
|
|
|
|
|||||
Cash – end of the period |
$ |
$ |
||||||
|
|
|
|
|||||
Supplemental disclosure of noncash activities: |
||||||||
Offering costs included in note payable |
$ | $ | — | |||||
|
|
|
|
|||||
General and administrative expenses paid by related party |
$ | $ | — | |||||
|
|
|
|
|||||
Initial classification of warrant liability |
$ | $ | — | |||||
|
|
|
|
|||||
Change in Class A common stock subject to possible redemption |
$ | $ | — | |||||
|
|
|
|
As Previously Reported |
Adjustment |
Restated |
||||||||||
Balance Sheet as of December 31, 2020 |
||||||||||||
Warrant liability |
$ | $ | $ | |||||||||
Total liabilities |
||||||||||||
Class A common stock subject to possible redemption |
( |
) | ||||||||||
Class A common stock |
||||||||||||
Additional paid-in capital |
||||||||||||
Accumulated deficit |
( |
) | ( |
) | ( |
) | ||||||
Total stockholders’ equity |
$ | $ | ( |
) | $ | |||||||
Statement of Operations for the year ended December 31, 2020 |
||||||||||||
Change in fair value of warrant liability |
$ | $ | ( |
) | $ | ( |
) | |||||
Loss before income tax expense |
( |
) | ( |
) | ( |
) | ||||||
Net loss |
( |
) | ( |
) | ( |
) | ||||||
Basic and diluted net loss per share, Class A – Public shares |
$ | $ | $ | |||||||||
Basic and diluted net loss per share, Class A – Private placement |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Basic and diluted net loss per share, Class B – Common stock |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Statement of Cash Flows for the year ended December 31, 2020 |
||||||||||||
Cash Flows from Operating Activities: |
||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Adjustments to reconcile net loss to net cash provided by operating activities: |
||||||||||||
Change in fair value of warrant liability |
||||||||||||
Net cash provided by operating activities |
||||||||||||
Non-Cash Investing and Financing Activities: |
||||||||||||
Initial classification of warrant liability |
$ | $ | $ | |||||||||
Change in Class A common stock subject to possible redemption |
$ | $ | ( |
) | $ |
For the Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Redeemable Class A common shares |
||||||||
Numerator: earnings allocable to redeemable Class A common shares |
||||||||
Interest income on investments held in Trust Account |
$ | $ | ||||||
|
|
|
|
|||||
Less franchise tax available to be withdrawn from the Trust Account |
$ | $ | ||||||
Net income |
$ | $ | ||||||
Denominator: weighted average number of redeemable Class A common share |
For the Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Basic and diluted net income per redeemable Class A common share |
$ | $ | ||||||
Non-redeemable Class A and Class B common shares |
||||||||
Numerator: net loss minus redeemable net earnings |
||||||||
Loss from operations |
$ | ( |
) | $ | ( |
) | ||
Less franchise tax available to be withdrawn from Trust Account |
||||||||
Change in fair value of warrant liability attributable to non-redeemable Class A common shares |
$ | ( |
) | $ | ||||
|
|
|
|
|||||
Non-redeemable net loss |
$ | ( |
) | $ | ( |
) | ||
Denominator: weighted average number of non-redeemable Class A and Class B common shares |
||||||||
Non-redeemable Class A private placement and Class B common shares, basic and diluted |
||||||||
Basic and diluted net loss per non-redeemable Class A private placement and Class B common share |
$ | ( |
) | $ | ( |
) |
• |
in whole and not in part; |
• |
at a price of $0.01 per warrant; |
• |
at any time during the exercise period; |
• |
upon a minimum of 30 days’ prior written notice of redemption; |
• |
if, and only if, the last reported sale price of the Company’s common stock equals or exceeds $18.00 per share for any 20-trading days within a 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders; and |
• |
if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants. |
December 31, |
||||||||
2020 |
2019 |
|||||||
Current |
||||||||
Federal |
$ | ( |
) | $ | ( |
) | ||
State |
||||||||
Deferred |
||||||||
Federal |
( |
) | ( |
) | ||||
State |
||||||||
Change in valuation allowance |
||||||||
Income tax provision expense |
$ | $ | ||||||
December 31, |
||||||||
2020 |
2019 |
|||||||
Deferred tax asset |
$ | $ | ||||||
Mark-to-Market Adjustments |
||||||||
Startup/Organizational Costs |
||||||||
Net operating loss carryforwards |
||||||||
Total deferred tax assets |
||||||||
Valuation Allowance |
( |
) | ( |
) | ||||
Deferred tax asset, net of allowance |
$ | $ | ||||||
December 31, |
||||||||
2020 |
2019 |
|||||||
Statutory Federal income tax rate |
% | % | ||||||
Change in Valuation Allowance |
( |
)% | ( |
)% | ||||
Income Taxes Benefit |
% | % | ||||||
• | Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
Description |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
Total |
||||||||||||
Assets: |
||||||||||||||||
Assets held in Trust Account U.S. Treasury Securities |
$ | $ | — | $ | — | $ | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities: |
||||||||||||||||
Warrant liability |
$ | — | $ | — | $ | $ | ||||||||||
|
|
|
|
|
|
|
|
November 17, 2020 (Initial Measurement) |
December 31, 2020 |
|||||||
Risk-free interest rate |
% | % | ||||||
Expected term (years) |
||||||||
Expected volatility |
% | % | ||||||
Exercise price |
$ | $ | ||||||
Stock price |
$ | $ | ||||||
Dividend yield |
% | % |
Private Placement |
Public |
Warrant Liability |
||||||||||
Fair value as of January 1, 2020 |
$ | $ | $ | |||||||||
Initial measurement on November 17, 2020 |
||||||||||||
Change in valuation inputs or other assumptions (1) |
||||||||||||
|
|
|
|
|
|
|||||||
Fair value as of December 31, 2020 |
$ | $ | $ | |||||||||
|
|
|
|
|
|
(1) |
Changes in valuation inputs or other assumptions are recognized in Change in fair value of warrant liability in the statement of operations. |
Item 13. |
Other Expenses of Issuance and Distribution. |
Amount |
||||
Securities and Exchange Commission registration fee |
$ | 65,538 | ||
Accounting fees and expenses |
50,000 | |||
Legal fees and expenses |
50,000 | |||
Financial printing and miscellaneous expenses |
25,000 | |||
|
|
|||
Total expenses |
$ | 190,278 |
Item 14. |
Indemnification of Directors and Officers. |
Item 15. |
Recent Sales of Unregistered Securities. |
Item 16. |
Exhibits and Financial Statement Schedules. |
Incorporated by Reference | ||||||||
Exhibit |
Description |
Form |
Exhibit |
Filing Date | ||||
24.1* | Power of Attorney (included on signature page of the initial filing of this Registration Statement) | |
|
| ||||
101.INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because iXBRL tags are embedded within the Inline XBRL document). | |||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document | |||||||
101.CAL | Inline XBRL Taxonomy Calculation Linkbase Document | |||||||
101.DEF | Inline XBRL Taxonomy Definition Linkbase Document | |||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||||||
104 | Cover Page Interactive Data File, formatted in Inline XBRL (included within the Exhibit 101 attachments). |
† | Certain exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5), which the Registrant agrees to furnish supplementally to the SEC upon its request. |
# | Filed Herewith. |
* | Previously filed. |
+ | Indicates a management contract or compensatory plan. |
Item 17. |
Undertakings. |
AEYE, INC. | ||
By: | /s/ Blair LaCorte | |
Name: Blair LaCorte | ||
Title: Chief Executive Officer |
Signature |
Title |
Date | ||
/s/ Blair LaCorte Blair LaCorte |
Chief Executive Officer and Director (Principal Executive Officer) |
September 23, 2021 | ||
/s/ Robert Brown Robert Brown |
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
September 23, 2021 | ||
* Luis Dussan |
Director | September 23, 2021 | ||
* Wen Hsieh |
Director | September 23, 2021 | ||
* Prof. Dr. Bernd Gottschalk |
Director | September 23, 2021 | ||
* Dr. Karl-Thomas Neumann |
Director | September 23, 2021 | ||
* Timothy J. Dunn |
Director | September 23, 2021 | ||
* Carol DiBattiste |
Director | September 23, 2021 |
*By: | /s/ Blair LaCorte | |
Blair LaCorte | ||
Attorney-in-Fact |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of our report dated May 12, 2021, relating to the financial statements of Aeye, Inc. We also consent to the reference to us under the heading Experts in such Registration Statement.
/s/ DELOITTE & TOUCHE LLP
San Francisco, California
September 23, 2021